| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 2.52e-11 | 11 | 126 | 6 | GO:0008503 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.69e-10 | 27 | 126 | 7 | GO:0008066 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 9.77e-10 | 18 | 126 | 6 | GO:0022851 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | GRIN2A GRIN2B GRM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.05e-09 | 75 | 126 | 9 | GO:0098960 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.14e-09 | 9 | 126 | 5 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.14e-09 | 9 | 126 | 5 | GO:0001640 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.42e-09 | 19 | 126 | 6 | GO:0004890 | |
| GeneOntologyMolecularFunction | transporter activity | NPC1 ATG9B SLC22A23 SLC26A5 CEACAM6 ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM7 TRPM5 SLC12A2 MFSD14B SLC15A2 SLC26A7 SLC25A39 SLC35D3 SLC22A4 SLC22A5 NPC1L1 LRP2 SFXN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.42e-09 | 1289 | 126 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.56e-09 | 57 | 126 | 8 | GO:1904315 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 3.85e-09 | 22 | 126 | 6 | GO:0016917 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.90e-09 | 60 | 126 | 8 | GO:0099529 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.87e-09 | 24 | 126 | 6 | GO:0099507 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 7.50e-09 | 65 | 126 | 8 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 7.50e-09 | 65 | 126 | 8 | GO:0022824 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | GRIN2A GRIN2B GRM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.39e-08 | 100 | 126 | 9 | GO:0030594 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 OR5B3 TPRA1 GPR37 INSRR MC5R GRIN2A GRIN2B GRM2 PKD1L3 GRM3 GRM5 GRM6 GRM7 NPFFR1 CCKAR SORCS1 OR5J2 NRXN3 NRXN1 NRXN2 GPR119 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.80e-08 | 1353 | 126 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.94e-08 | 77 | 126 | 8 | GO:0005230 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 4.66e-08 | 54 | 126 | 7 | GO:0005246 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC22A23 SLC26A5 CEACAM6 ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM7 TRPM5 SLC12A2 MFSD14B SLC15A2 SLC26A7 SLC25A39 SLC35D3 SLC22A4 SLC22A5 SFXN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.72e-08 | 1180 | 126 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | SLC26A5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 9.82e-08 | 125 | 126 | 9 | GO:0015108 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC26A5 ABCC5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.34e-07 | 171 | 126 | 10 | GO:0015103 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | SLC26A5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.94e-07 | 151 | 126 | 9 | GO:0008509 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 7.09e-07 | 50 | 126 | 6 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.20e-06 | 86 | 126 | 7 | GO:0005254 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 2.43e-06 | 5 | 126 | 3 | GO:0097109 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | GRIN2A GRIN2B TRPM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.80e-06 | 193 | 126 | 9 | GO:0015276 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 4.04e-06 | 103 | 126 | 7 | GO:0005253 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | GRIN2A GRIN2B TRPM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.49e-06 | 197 | 126 | 9 | GO:0022834 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC26A5 ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM7 TRPM5 SLC12A2 SLC15A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.69e-06 | 758 | 126 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC26A5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM7 TRPM5 SLC12A2 SLC15A2 SLC26A7 SFXN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.03e-05 | 793 | 126 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 2.00e-05 | 9 | 126 | 3 | GO:0042937 | |
| GeneOntologyMolecularFunction | channel activity | GRIN2A GRIN2B PKD1L3 GRM7 TRPM5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.82e-05 | 525 | 126 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GRIN2A GRIN2B PKD1L3 GRM7 TRPM5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.87e-05 | 526 | 126 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GRIN2A GRIN2B PKD1L3 GRM7 TRPM5 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.44e-05 | 459 | 126 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | group II metabotropic glutamate receptor activity | 3.95e-05 | 2 | 126 | 2 | GO:0001641 | |
| GeneOntologyMolecularFunction | gated channel activity | GRIN2A GRIN2B GRM7 TRPM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.20e-05 | 334 | 126 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 5.37e-05 | 33 | 126 | 4 | GO:0072349 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 7.64e-05 | 162 | 126 | 7 | GO:0099106 | |
| GeneOntologyMolecularFunction | glutamate binding | 8.49e-05 | 14 | 126 | 3 | GO:0016595 | |
| GeneOntologyMolecularFunction | diazepam binding | 1.18e-04 | 3 | 126 | 2 | GO:0050809 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.20e-04 | 174 | 126 | 7 | GO:0016247 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 1.29e-04 | 16 | 126 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 1.33e-04 | 177 | 126 | 7 | GO:0141108 | |
| GeneOntologyMolecularFunction | amino-acid betaine transmembrane transporter activity | 2.35e-04 | 4 | 126 | 2 | GO:0015199 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 2.35e-04 | 4 | 126 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 2.35e-04 | 4 | 126 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC26A5 CEACAM6 ABCC5 GRIN2A GRIN2B SLC26A7 SLC25A39 SLC35D3 | 5.50e-04 | 293 | 126 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 5.83e-04 | 6 | 126 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A5 SLC30A1 SLC12A2 SLC15A2 SLC26A7 SLC35D3 SLC22A4 SLC22A5 | 5.88e-04 | 296 | 126 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 5.97e-04 | 61 | 126 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 8.13e-04 | 7 | 126 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | glutathione transmembrane transporter activity | 8.13e-04 | 7 | 126 | 2 | GO:0034634 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.69e-04 | 31 | 126 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.08e-03 | 8 | 126 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.08e-03 | 8 | 126 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.10e-03 | 123 | 126 | 5 | GO:0030165 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.36e-03 | 129 | 126 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5B3 TPRA1 GPR37 MC5R GRM2 GRM3 GRM5 GRM6 GRM7 NPFFR1 CCKAR SORCS1 OR5J2 GPR119 | 1.39e-03 | 884 | 126 | 14 | GO:0004930 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.56e-03 | 133 | 126 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.72e-03 | 10 | 126 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.95e-03 | 140 | 126 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.35e-03 | 42 | 126 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.71e-03 | 151 | 126 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.86e-03 | 93 | 126 | 4 | GO:0097110 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 2.94e-03 | 13 | 126 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 2.94e-03 | 13 | 126 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC26A5 ABCC5 SLC30A1 SLC12A2 SLC15A2 SLC26A7 SLC35D3 SLC22A4 SLC22A5 | 3.29e-03 | 477 | 126 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 3.46e-03 | 98 | 126 | 4 | GO:0048306 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 3.93e-03 | 15 | 126 | 2 | GO:0015651 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 3.93e-03 | 15 | 126 | 2 | GO:0051011 | |
| GeneOntologyMolecularFunction | alcohol binding | 3.99e-03 | 102 | 126 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 4.47e-03 | 16 | 126 | 2 | GO:0015116 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 4.57e-03 | 53 | 126 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 4.84e-03 | 173 | 126 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 5.05e-03 | 17 | 126 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | cholesterol binding | 5.88e-03 | 58 | 126 | 3 | GO:0015485 | |
| GeneOntologyMolecularFunction | myosin V binding | 6.97e-03 | 20 | 126 | 2 | GO:0031489 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 6.97e-03 | 20 | 126 | 2 | GO:0050811 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 2.98e-11 | 35 | 125 | 8 | GO:0007214 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 9.32e-10 | 9 | 125 | 5 | GO:0007196 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 NRXN3 SLC12A2 NRXN1 NRXN2 LNPEP PLCL2 VPS13A BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.59e-09 | 931 | 125 | 24 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 NRXN3 SLC12A2 NRXN1 NRXN2 LNPEP PLCL2 VPS13A BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.59e-09 | 931 | 125 | 24 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 NRXN3 SLC12A2 NRXN1 NRXN2 LNPEP PLCL2 VPS13A BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.88e-09 | 939 | 125 | 24 | GO:0099537 |
| GeneOntologyBiologicalProcess | synaptic signaling | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 NRXN3 SLC12A2 NRXN1 NRXN2 LNPEP PLCL2 VPS13A BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.02e-09 | 976 | 125 | 24 | GO:0099536 |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 1.57e-08 | 74 | 125 | 8 | GO:0051932 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 2.31e-08 | 30 | 125 | 6 | GO:1904862 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | SLC26A5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.68e-08 | 112 | 125 | 9 | GO:1902476 |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 3.12e-08 | 16 | 125 | 5 | GO:0007216 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | SLC26A5 ABCC5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.21e-08 | 153 | 125 | 10 | GO:0098656 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | WFS1 CAMK2B SLC22A23 SLC26A5 ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM6 CCKAR TRPM5 SLC12A2 SLC15A2 SLC26A7 SLC22A4 SLC22A5 SERPINE1 LRP2 SFXN2 NNT GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.28e-08 | 1374 | 125 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 6.66e-08 | 59 | 125 | 7 | GO:0007215 | |
| GeneOntologyBiologicalProcess | chloride transport | SLC26A5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 8.57e-08 | 128 | 125 | 9 | GO:0006821 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 8.83e-08 | 92 | 125 | 8 | GO:0051966 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 NRXN3 SLC12A2 NRXN1 NRXN2 LNPEP PLCL2 VPS13A BSN | 1.03e-07 | 663 | 125 | 18 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 NRXN3 SLC12A2 NRXN1 NRXN2 LNPEP PLCL2 VPS13A BSN | 1.06e-07 | 664 | 125 | 18 | GO:0099177 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | SLC26A5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.27e-07 | 134 | 125 | 9 | GO:0098661 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | GRIN2A GRIN2B GRM5 NRXN1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.49e-07 | 180 | 125 | 10 | GO:0060078 |
| GeneOntologyBiologicalProcess | synapse organization | TNC CAMK2B GRIN2A GRIN2B GRM5 SLC30A1 GRM6 MFN1 NRXN3 NRXN1 NRXN2 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.68e-07 | 685 | 125 | 18 | GO:0050808 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | SLC26A5 ABCC5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.74e-07 | 183 | 125 | 10 | GO:0006820 |
| GeneOntologyBiologicalProcess | cell junction organization | DSG2 TNC CAMK2B CEACAM6 GRIN2A GRIN2B GRM5 SLC30A1 GRM6 MFN1 NRXN3 NRXN1 NRXN2 MACF1 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.87e-07 | 974 | 125 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | behavior | NPC1 KLHL1 WFS1 GPR37 CEACAM6 GRIN2A GRIN2B GRM2 GRM5 GRM6 GRM7 CCKAR NRXN3 NRXN1 NRXN2 SLC22A5 VPS13A NAV2 OTOG GABRA5 | 4.05e-07 | 891 | 125 | 20 | GO:0007610 |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 6.92e-07 | 120 | 125 | 8 | GO:0006835 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.43e-06 | 132 | 125 | 8 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | DSG2 SLC26A5 GRIN2A GRIN2B GRM5 MFN1 NUP155 NRXN1 NNT GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.51e-06 | 559 | 125 | 15 | GO:0042391 |
| GeneOntologyBiologicalProcess | inorganic anion transport | SLC26A5 SLC12A2 SLC26A7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.54e-06 | 180 | 125 | 9 | GO:0015698 |
| GeneOntologyBiologicalProcess | synapse assembly | GRM6 NRXN3 NRXN1 NRXN2 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.82e-06 | 308 | 125 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | adult behavior | 4.14e-06 | 203 | 125 | 9 | GO:0030534 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 4.19e-06 | 40 | 125 | 5 | GO:0048169 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 6.78e-06 | 44 | 125 | 5 | GO:0072337 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 9.21e-06 | 284 | 125 | 10 | GO:0007626 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.39e-05 | 86 | 125 | 6 | GO:0007193 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.49e-05 | 238 | 125 | 9 | GO:0050954 | |
| GeneOntologyBiologicalProcess | tripeptide transmembrane transport | 2.53e-05 | 10 | 125 | 3 | GO:0035443 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 3.46e-05 | 11 | 125 | 3 | GO:0097119 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC26A5 ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM6 TRPM5 SLC12A2 SLC15A2 SLC26A7 NNT GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.15e-05 | 1017 | 125 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC26A5 ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM6 TRPM5 SLC12A2 SLC15A2 SLC26A7 SFXN2 NNT GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.16e-05 | 1115 | 125 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | learning | 4.59e-05 | 212 | 125 | 8 | GO:0007612 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 4.66e-05 | 65 | 125 | 5 | GO:0072348 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 5.39e-05 | 67 | 125 | 5 | GO:0099171 | |
| GeneOntologyBiologicalProcess | tripeptide transport | 5.94e-05 | 13 | 125 | 3 | GO:0042939 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 6.28e-05 | 286 | 125 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC26A5 CEACAM6 ABCC5 GRIN2B GRM2 GRM7 SLC12A2 SLC26A7 SLC25A39 SLC35D3 LRP2 SFXN2 | 7.06e-05 | 515 | 125 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | neuron projection development | KLHL1 SZT2 TNC GPR37 CAMK2B LAMC3 FRYL ZSWIM6 SLC30A1 GRM7 MFN1 CCKAR ATL1 NRXN3 NRXN1 VPS13A LRP2 MACF1 OTOG NIN | 9.02e-05 | 1285 | 125 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | RAB25 SZT2 CAMK2B SLC26A5 LAMC3 FRYL ZSWIM6 SLC30A1 FMNL2 MFN1 CCKAR ATL1 FAT1 NRXN3 NRXN1 VPS13A LRP2 MACF1 NIN | 1.03e-04 | 1194 | 125 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.15e-04 | 16 | 125 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 1.33e-04 | 247 | 125 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | oligopeptide transmembrane transport | 1.39e-04 | 17 | 125 | 3 | GO:0035672 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 1.50e-04 | 83 | 125 | 5 | GO:0048168 | |
| GeneOntologyBiologicalProcess | cell junction assembly | GRM6 NRXN3 NRXN1 NRXN2 MACF1 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.80e-04 | 569 | 125 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | neuron development | KLHL1 SZT2 TNC GPR37 CAMK2B LAMC3 FRYL ZSWIM6 SLC30A1 GRM7 MFN1 CCKAR ATL1 NRXN3 NRXN1 VPS13A LRP2 MACF1 OTOG GABRA5 NIN | 1.83e-04 | 1463 | 125 | 21 | GO:0048666 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.87e-04 | 87 | 125 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.98e-04 | 88 | 125 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC26A5 CEACAM6 ABCC5 GRIN2B GRM2 GRM7 SLC12A2 SLC26A7 LRP2 SFXN2 | 2.01e-04 | 410 | 125 | 10 | GO:0046942 |
| GeneOntologyBiologicalProcess | export from cell | SNX4 RAB25 TCP11 ABCC5 GRIN2B GRM2 SLC30A1 GRM7 RFX3 CCKAR NRXN3 SLC12A2 NRXN1 NRXN2 SLC15A2 SLC22A5 VPS13A GPR119 | 2.03e-04 | 1153 | 125 | 18 | GO:0140352 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.07e-04 | 198 | 125 | 7 | GO:0007605 | |
| GeneOntologyBiologicalProcess | organic acid transport | SLC26A5 CEACAM6 ABCC5 GRIN2B GRM2 GRM7 SLC12A2 SLC26A7 LRP2 SFXN2 | 2.09e-04 | 412 | 125 | 10 | GO:0015849 |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 2.17e-04 | 4 | 125 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 2.30e-04 | 20 | 125 | 3 | GO:0014733 | |
| GeneOntologyBiologicalProcess | oligopeptide transport | 3.52e-04 | 23 | 125 | 3 | GO:0006857 | |
| GeneOntologyBiologicalProcess | folate transmembrane transport | 3.60e-04 | 5 | 125 | 2 | GO:0098838 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 3.60e-04 | 5 | 125 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 3.60e-04 | 5 | 125 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SZT2 CAMK2B LAMC3 ZSWIM6 SLC30A1 MFN1 CCKAR ATL1 NRXN3 NRXN1 VPS13A LRP2 MACF1 NIN | 3.63e-04 | 802 | 125 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | vitamin transport | 3.70e-04 | 56 | 125 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 4.01e-04 | 24 | 125 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 4.23e-04 | 58 | 125 | 4 | GO:0097106 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SZT2 CAMK2B LAMC3 ZSWIM6 SLC30A1 MFN1 CCKAR ATL1 NRXN3 NRXN1 VPS13A LRP2 MACF1 NIN | 4.48e-04 | 819 | 125 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of amino acid transport | 4.82e-04 | 60 | 125 | 4 | GO:0051955 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SZT2 CAMK2B LAMC3 ZSWIM6 SLC30A1 MFN1 CCKAR ATL1 NRXN3 NRXN1 VPS13A LRP2 MACF1 NIN | 4.87e-04 | 826 | 125 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling, modulating synaptic transmission | 5.10e-04 | 26 | 125 | 3 | GO:0099550 | |
| GeneOntologyBiologicalProcess | regulation of glutamate secretion | 5.71e-04 | 27 | 125 | 3 | GO:0014048 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 6.17e-04 | 64 | 125 | 4 | GO:0042908 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | WFS1 CAMK2B ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM6 CCKAR TRPM5 SLC12A2 SLC15A2 SLC22A4 SLC22A5 SERPINE1 LRP2 NNT | 6.18e-04 | 1157 | 125 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | postsynapse organization | 6.51e-04 | 313 | 125 | 8 | GO:0099173 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 6.80e-04 | 115 | 125 | 5 | GO:0097061 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 6.80e-04 | 115 | 125 | 5 | GO:0035418 | |
| GeneOntologyBiologicalProcess | vocal learning | 7.50e-04 | 7 | 125 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | imitative learning | 7.50e-04 | 7 | 125 | 2 | GO:0098596 | |
| GeneOntologyBiologicalProcess | carnitine transmembrane transport | 7.50e-04 | 7 | 125 | 2 | GO:1902603 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 9.13e-04 | 71 | 125 | 4 | GO:0099084 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 9.32e-04 | 185 | 125 | 6 | GO:0099175 | |
| GeneOntologyBiologicalProcess | skeletal muscle adaptation | 9.48e-04 | 32 | 125 | 3 | GO:0043501 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 9.48e-04 | 32 | 125 | 3 | GO:0099505 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular wound healing | 9.96e-04 | 8 | 125 | 2 | GO:0061044 | |
| GeneOntologyBiologicalProcess | glutathione transmembrane transport | 9.96e-04 | 8 | 125 | 2 | GO:0034775 | |
| GeneOntologyBiologicalProcess | corpus callosum morphogenesis | 9.96e-04 | 8 | 125 | 2 | GO:0021540 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by lipid, modulating synaptic transmission | 9.96e-04 | 8 | 125 | 2 | GO:0099552 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission | 9.96e-04 | 8 | 125 | 2 | GO:0099553 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.02e-03 | 418 | 125 | 9 | GO:0051962 | |
| GeneOntologyBiologicalProcess | digestive system process | 1.03e-03 | 126 | 125 | 5 | GO:0022600 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 1.06e-03 | 127 | 125 | 5 | GO:0106027 | |
| GeneOntologyBiologicalProcess | social behavior | 1.07e-03 | 74 | 125 | 4 | GO:0035176 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 1.07e-03 | 74 | 125 | 4 | GO:0050885 | |
| GeneOntologyBiologicalProcess | metal ion transport | WFS1 CAMK2B ABCC5 GRIN2A GRIN2B PKD1L3 SLC30A1 GRM6 CCKAR TRPM5 SLC12A2 SLC22A4 SLC22A5 SERPINE1 LRP2 | 1.07e-03 | 1000 | 125 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion transport | WFS1 CAMK2B GRIN2A GRIN2B PKD1L3 SLC30A1 GRM6 CCKAR TRPM5 SERPINE1 | 1.08e-03 | 509 | 125 | 10 | GO:0006816 |
| GeneOntologyBiologicalProcess | cognition | 1.11e-03 | 423 | 125 | 9 | GO:0050890 | |
| GeneOntologyBiologicalProcess | localization within membrane | NPC1 NHLRC1 SNX4 CAMK2B GRIN2A GRIN2B SLC30A1 NRXN3 NUP155 NRXN1 NRXN2 MACF1 GPC5 | 1.12e-03 | 798 | 125 | 13 | GO:0051668 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.12e-03 | 75 | 125 | 4 | GO:0050982 | |
| GeneOntologyCellularComponent | synaptic membrane | HIP1 GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 SSPN NRXN3 NRXN1 NRXN2 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.19e-10 | 583 | 126 | 20 | GO:0097060 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.08e-09 | 19 | 126 | 6 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 2.14e-09 | 21 | 126 | 6 | GO:1902710 | |
| GeneOntologyCellularComponent | postsynaptic membrane | HIP1 GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 SSPN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.00e-09 | 405 | 126 | 16 | GO:0045211 |
| GeneOntologyCellularComponent | dendrite | KLHL1 WFS1 GPR37 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 TRPM5 LRP2 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 NIN | 8.51e-09 | 858 | 126 | 22 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | KLHL1 WFS1 GPR37 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 TRPM5 LRP2 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 NIN | 8.88e-09 | 860 | 126 | 22 | GO:0097447 |
| GeneOntologyCellularComponent | presynaptic membrane | HIP1 GRIN2A GRIN2B GRM2 GRM3 GRM7 NRXN3 NRXN1 NRXN2 GABRA2 GABRA3 GABRA5 GABRA6 | 1.32e-08 | 277 | 126 | 13 | GO:0042734 |
| GeneOntologyCellularComponent | somatodendritic compartment | KLHL1 WFS1 GPR37 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 TRPM5 SLC12A2 NRXN1 LNPEP VPS13A LRP2 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 NIN | 1.63e-08 | 1228 | 126 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite membrane | 4.44e-08 | 56 | 126 | 7 | GO:0032590 | |
| GeneOntologyCellularComponent | cell projection membrane | RAB25 CEACAM6 GRIN2A APPL2 SLC12A2 SLC22A5 NPC1L1 LRP2 MACF1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.18e-08 | 431 | 126 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | GABA-ergic synapse | GRM7 NRXN3 NRXN1 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.91e-08 | 164 | 126 | 10 | GO:0098982 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.89e-07 | 141 | 126 | 9 | GO:0048786 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | GRIN2A GRIN2B GRM5 SLC30A1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.95e-07 | 201 | 126 | 10 | GO:0099634 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 4.53e-07 | 78 | 126 | 7 | GO:0048787 | |
| GeneOntologyCellularComponent | neuron projection membrane | 6.39e-07 | 82 | 126 | 7 | GO:0032589 | |
| GeneOntologyCellularComponent | chloride channel complex | 1.20e-06 | 57 | 126 | 6 | GO:0034707 | |
| GeneOntologyCellularComponent | postsynaptic specialization | CAMK2B GRIN2A GRIN2B GRM3 GRM5 SLC30A1 MACF1 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.14e-06 | 503 | 126 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | receptor complex | GPR37 INSRR CEACAM6 GRIN2A GRIN2B PKD1L3 GRM7 LRP2 GPR119 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.29e-06 | 581 | 126 | 15 | GO:0043235 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | NPC1 ATG9B SNX4 HIP1 WFS1 CAMK2B CEACAM6 ABCC5 GRIN2A GRIN2B SLC30A1 APPL2 SLC12A2 SLC15A2 SLC26A7 LNPEP SLC35D3 NPC1L1 VPS13A LRP2 BSN GABRA1 GABRA2 | 3.10e-06 | 1307 | 126 | 23 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | NPC1 ATG9B SNX4 HIP1 WFS1 CAMK2B CEACAM6 ABCC5 GRIN2A GRIN2B SLC30A1 APPL2 SLC12A2 SLC15A2 SLC26A7 LNPEP SLC35D3 NPC1L1 VPS13A LRP2 BSN GABRA1 GABRA2 | 3.90e-06 | 1325 | 126 | 23 | GO:0012506 |
| GeneOntologyCellularComponent | leading edge membrane | GRIN2A APPL2 MACF1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.24e-06 | 210 | 126 | 9 | GO:0031256 |
| GeneOntologyCellularComponent | presynapse | SNX4 HIP1 WFS1 GRIN2A GRIN2B GRM2 GRM3 GRM7 CCKAR NRXN3 NRXN1 NRXN2 SLC35D3 BSN GABRA2 GABRA3 GABRA5 GABRA6 | 6.15e-06 | 886 | 126 | 18 | GO:0098793 |
| GeneOntologyCellularComponent | apical plasma membrane | DSG2 CEACAM6 ABCC5 DUOX2 FAT1 SLC12A2 SLC15A2 SLC26A7 SLC22A4 SLC22A5 NPC1L1 LRP2 OTOG | 7.91e-06 | 487 | 126 | 13 | GO:0016324 |
| GeneOntologyCellularComponent | postsynapse | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 SLC30A1 GRM6 GRM7 SSPN MACF1 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.11e-05 | 1018 | 126 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | apical part of cell | DSG2 CEACAM6 ABCC5 DUOX2 FAT1 SLC12A2 SLC15A2 SLC26A7 SLC22A4 SLC22A5 NPC1L1 LRP2 OTOG NIN | 1.37e-05 | 592 | 126 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | cell leading edge | DUOX2 GRIN2A FAT1 APPL2 AMOT MACF1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.07e-05 | 500 | 126 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GRIN2A GRIN2B PKD1L3 TRPM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 9.95e-05 | 378 | 126 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.14e-04 | 90 | 126 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | CAMK2B GRIN2A GRIN2B GRM3 GRM5 SLC30A1 GRM7 NRXN1 MACF1 BSN GABRA6 | 3.30e-04 | 523 | 126 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | transmembrane transporter complex | FOXRED1 GRIN2A GRIN2B PKD1L3 TRPM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.30e-04 | 523 | 126 | 11 | GO:1902495 |
| GeneOntologyCellularComponent | GATOR1 complex | 3.56e-04 | 5 | 126 | 2 | GO:1990130 | |
| GeneOntologyCellularComponent | astrocyte projection | 4.46e-04 | 25 | 126 | 3 | GO:0097449 | |
| GeneOntologyCellularComponent | transporter complex | FOXRED1 GRIN2A GRIN2B PKD1L3 TRPM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.03e-04 | 550 | 126 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | inhibitory synapse | 8.50e-04 | 31 | 126 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.26e-03 | 9 | 126 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC26A5 CEACAM6 ABCC5 SLC30A1 SLC12A2 SLC26A7 SLC22A4 SLC22A5 | 1.39e-03 | 354 | 126 | 8 | GO:0009925 |
| GeneOntologyCellularComponent | neuronal cell body | KLHL1 CAMK2B GRIN2B GRM7 TRPM5 SLC12A2 NRXN1 LNPEP VPS13A BSN GABRA2 GABRA5 GABRA6 | 1.60e-03 | 835 | 126 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | basal part of cell | SLC26A5 CEACAM6 ABCC5 SLC30A1 SLC12A2 SLC26A7 SLC22A4 SLC22A5 | 2.09e-03 | 378 | 126 | 8 | GO:0045178 |
| GeneOntologyCellularComponent | asymmetric synapse | 2.43e-03 | 477 | 126 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.50e-03 | 155 | 126 | 5 | GO:0098685 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.52e-03 | 45 | 126 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | terminal bouton | 2.73e-03 | 96 | 126 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | axon | INSRR GRIN2A GRIN2B GRM2 GRM3 GRM7 CCKAR ATL1 NRXN1 LRP2 BSN GABRA2 NIN | 2.82e-03 | 891 | 126 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | cell surface | DSG2 GPR37 MUC16 CEACAM6 DUOX2 GRIN2A GRIN2B PKD1L3 GRM7 NRXN1 LNPEP AMOT LRP2 GPC5 BSN | 2.84e-03 | 1111 | 126 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | glial cell projection | 2.86e-03 | 47 | 126 | 3 | GO:0097386 | |
| GeneOntologyCellularComponent | cell body membrane | 2.86e-03 | 47 | 126 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 3.22e-03 | 49 | 126 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.30e-03 | 320 | 126 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | membrane protein complex | SNX4 FOXRED1 INSRR CEACAM6 DUOX2 GRIN2A GRIN2B PKD1L3 MFN1 SSPN TRPM5 NNT GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.80e-03 | 1498 | 126 | 18 | GO:0098796 |
| GeneOntologyCellularComponent | glutamatergic synapse | HIP1 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 GRM7 NRXN3 NRXN1 NRXN2 BSN | 3.88e-03 | 817 | 126 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | cell body | KLHL1 CAMK2B GRIN2B GRM7 TRPM5 SLC12A2 NRXN1 LNPEP VPS13A BSN GABRA2 GABRA5 GABRA6 | 4.02e-03 | 929 | 126 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | excitatory synapse | 4.03e-03 | 107 | 126 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | Seh1-associated complex | 4.09e-03 | 16 | 126 | 2 | GO:0035859 | |
| GeneOntologyCellularComponent | Golgi lumen | 4.30e-03 | 109 | 126 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | interstitial matrix | 4.62e-03 | 17 | 126 | 2 | GO:0005614 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.70e-03 | 56 | 126 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | postsynaptic density | 6.06e-03 | 451 | 126 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | lysosomal membrane | 6.97e-03 | 462 | 126 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 6.97e-03 | 462 | 126 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 7.74e-03 | 67 | 126 | 3 | GO:0098686 | |
| HumanPheno | Bilateral tonic-clonic seizure | NHLRC1 SZT2 CAMK2B LAMC3 GRIN2A GRIN2B GRM7 SLC22A5 VPS13A MACF1 DEPDC5 CAMTA1 GABRA1 GABRA3 GABRA5 | 2.31e-07 | 394 | 42 | 15 | HP:0002069 |
| HumanPheno | Focal-onset seizure | NHLRC1 SZT2 CAMK2B LAMC3 GRIN2A GRIN2B GRM7 SLC22A5 MACF1 DEPDC5 CAMTA1 GABRA1 GABRA3 GABRA5 | 3.16e-07 | 346 | 42 | 14 | HP:0007359 |
| HumanPheno | Focal impaired awareness seizure | NHLRC1 CAMK2B LAMC3 GRIN2A GRIN2B MACF1 DEPDC5 GABRA1 GABRA3 | 5.83e-07 | 126 | 42 | 9 | HP:0002384 |
| HumanPheno | Autistic behavior | FOXRED1 SZT2 WFS1 CAMK2B PSMD12 GRIN2A GRIN2B ZSWIM6 GRM7 SLC12A2 ASXL3 GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 2.15e-06 | 678 | 42 | 18 | HP:0000729 |
| HumanPheno | Dialeptic seizure | NHLRC1 SZT2 CAMK2B LAMC3 GRIN2A GRIN2B GRM7 MACF1 DEPDC5 GABRA1 GABRA3 | 3.67e-06 | 251 | 42 | 11 | HP:0011146 |
| HumanPheno | Focal motor seizure | 8.73e-06 | 131 | 42 | 8 | HP:0011153 | |
| HumanPheno | Diagnostic behavioral phenotype | FOXRED1 SZT2 WFS1 CAMK2B PSMD12 GRIN2A GRIN2B ZSWIM6 GRM7 SLC12A2 ASXL3 GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 8.83e-06 | 747 | 42 | 18 | HP:0025783 |
| HumanPheno | Generalized-onset seizure | NHLRC1 SZT2 CAMK2B LAMC3 GRIN2A GRIN2B GRM7 SLC22A5 VPS13A MACF1 DEPDC5 CAMTA1 GABRA1 GABRA3 GABRA5 | 1.40e-05 | 544 | 42 | 15 | HP:0002197 |
| HumanPheno | Motor seizure | NHLRC1 SZT2 CAMK2B LAMC3 GRIN2A GRIN2B GRM7 SLC22A5 VPS13A MACF1 DEPDC5 CAMTA1 GABRA1 GABRA3 GABRA5 | 3.45e-05 | 586 | 42 | 15 | HP:0020219 |
| HumanPheno | Status epilepticus | 3.52e-05 | 207 | 42 | 9 | HP:0002133 | |
| HumanPheno | Abnormal hippocampus morphology | 3.93e-05 | 48 | 42 | 5 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 4.35e-05 | 49 | 42 | 5 | HP:0007343 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 5.82e-05 | 52 | 42 | 5 | HP:0007334 | |
| HumanPheno | Motor stereotypy | CAMK2B GRIN2A ZSWIM6 TRANK1 ASXL3 VPS13A MACF1 DEPDC5 CAMTA1 GABRA1 | 6.57e-05 | 280 | 42 | 10 | HP:0000733 |
| HumanPheno | Generalized-onset motor seizure | 7.53e-05 | 228 | 42 | 9 | HP:0032677 | |
| HumanPheno | Abnormal motivation | NHLRC1 FOXRED1 SZT2 WFS1 CAMK2B CEACAM6 DUOX2 PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 SLC22A5 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 1.05e-04 | 1263 | 42 | 22 | HP:5200275 |
| HumanPheno | Abnormal volitional state | NHLRC1 FOXRED1 SZT2 WFS1 CAMK2B CEACAM6 DUOX2 PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 SLC22A5 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 1.05e-04 | 1263 | 42 | 22 | HP:0025780 |
| HumanPheno | Tonic seizure | 1.23e-04 | 140 | 42 | 7 | HP:0032792 | |
| HumanPheno | Abnormal social development | FOXRED1 SZT2 CAMK2B PSMD12 GRIN2A GRIN2B ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 1.33e-04 | 908 | 42 | 18 | HP:0025732 |
| HumanPheno | Restricted or repetitive behaviors or interests | CAMK2B GRIN2A ZSWIM6 TRANK1 ASXL3 VPS13A GTF2IRD2 MACF1 DEPDC5 CAMTA1 GABRA1 | 1.34e-04 | 368 | 42 | 11 | HP:0031432 |
| HumanPheno | Perseverative thought | CAMK2B GRIN2A ZSWIM6 TRANK1 ASXL3 VPS13A GTF2IRD2 MACF1 DEPDC5 CAMTA1 GABRA1 | 1.66e-04 | 377 | 42 | 11 | HP:0030223 |
| HumanPheno | Gastroesophageal reflux | SZT2 CAMK2B CEACAM6 ZSWIM6 ATL1 SLC12A2 NRXN1 ASXL3 GTF2IRD2 CAMTA1 STAG2 GABRA2 GABRA5 | 1.66e-04 | 517 | 42 | 13 | HP:0002020 |
| HumanPheno | Abnormal esophagus physiology | NPC1 SZT2 WFS1 CAMK2B CEACAM6 ZSWIM6 GRM7 ATL1 SLC12A2 NRXN1 ASXL3 VPS13A GTF2IRD2 MACF1 CAMTA1 STAG2 GABRA2 GABRA5 | 1.91e-04 | 933 | 42 | 18 | HP:0025270 |
| HumanPheno | Disordered formal thought process | CAMK2B GRIN2A ZSWIM6 TRANK1 ASXL3 VPS13A GTF2IRD2 MACF1 DEPDC5 CAMTA1 GABRA1 | 2.05e-04 | 386 | 42 | 11 | HP:0025769 |
| HumanPheno | EEG with generalized epileptiform discharges | 2.75e-04 | 270 | 42 | 9 | HP:0011198 | |
| HumanPheno | Involuntary movements | NHLRC1 FOXRED1 SZT2 WFS1 CAMK2B GRIN2A GRIN2B ZSWIM6 GRM7 ATL1 TRANK1 ASXL3 VPS13A GTF2IRD2 MACF1 DEPDC5 CAMTA1 GABRA1 GABRA2 GABRA3 GABRA5 | 2.94e-04 | 1248 | 42 | 21 | HP:0004305 |
| HumanPheno | Abnormal thought pattern | CAMK2B GRIN2A ZSWIM6 TRANK1 ASXL3 VPS13A GTF2IRD2 MACF1 DEPDC5 CAMTA1 GABRA1 | 3.06e-04 | 404 | 42 | 11 | HP:5200269 |
| HumanPheno | Hyperventilation | 3.24e-04 | 41 | 42 | 4 | HP:0002883 | |
| HumanPheno | Disinhibition | SZT2 CAMK2B PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 3.85e-04 | 807 | 42 | 16 | HP:0000734 |
| HumanPheno | Inappropriate behavior | SZT2 CAMK2B PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 3.85e-04 | 807 | 42 | 16 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | SZT2 CAMK2B PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 3.85e-04 | 807 | 42 | 16 | HP:5200123 |
| HumanPheno | Social disinhibition | SZT2 CAMK2B PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 3.85e-04 | 807 | 42 | 16 | HP:5200029 |
| HumanPheno | Recurrent maladaptive behavior | NHLRC1 SZT2 WFS1 CAMK2B CEACAM6 PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 MACF1 DEPDC5 CAMTA1 NNT STAG2 GABRA1 GABRA2 GABRA5 | 4.96e-04 | 1293 | 42 | 21 | HP:5200241 |
| HumanPheno | Atypical absence seizure | 5.07e-04 | 46 | 42 | 4 | HP:0007270 | |
| HumanPheno | Developmental regression | SZT2 WFS1 CAMK2B GRIN2A GRIN2B GRM7 NRXN1 GTF2IRD2 GABRA1 GABRA2 GABRA5 | 6.39e-04 | 440 | 42 | 11 | HP:0002376 |
| HumanPheno | Aggressive behavior | SZT2 CAMK2B PSMD12 GRIN2A GRM7 ASXL3 VPS13A DEPDC5 CAMTA1 GABRA1 GABRA2 GABRA5 | 6.59e-04 | 516 | 42 | 12 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | SZT2 CAMK2B PSMD12 GRIN2A GRM7 ASXL3 VPS13A DEPDC5 CAMTA1 GABRA1 GABRA2 GABRA5 | 6.59e-04 | 516 | 42 | 12 | HP:0006919 |
| HumanPheno | Hypsarrhythmia | 6.82e-04 | 185 | 42 | 7 | HP:0002521 | |
| HumanPheno | Sleep abnormality | NHLRC1 WFS1 CAMK2B DUOX2 GRIN2A GRM7 TRANK1 ASXL3 SLC22A5 VPS13A GTF2IRD2 DEPDC5 STAG2 | 6.84e-04 | 596 | 42 | 13 | HP:0002360 |
| HumanPheno | Reduced impulse control | SZT2 WFS1 CAMK2B PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 NNT STAG2 GABRA1 GABRA2 GABRA5 | 7.01e-04 | 1032 | 42 | 18 | HP:5200045 |
| HumanPheno | EEG with multifocal slow activity | 8.12e-04 | 52 | 42 | 4 | HP:0010844 | |
| HumanPheno | Impairment in personality functioning | NHLRC1 SZT2 WFS1 CAMK2B CEACAM6 PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 8.25e-04 | 1141 | 42 | 19 | HP:0031466 |
| HumanPheno | Abnormally increased volition | SZT2 CAMK2B PSMD12 GRIN2A ZSWIM6 GRM7 TRANK1 ASXL3 VPS13A GTF2IRD2 DEPDC5 CAMTA1 STAG2 GABRA1 GABRA2 GABRA5 | 9.02e-04 | 869 | 42 | 16 | HP:5200263 |
| HumanPheno | Hypertonia | NPC1 NHLRC1 FOXRED1 SZT2 CAMK2B GRIN2A GRIN2B ZSWIM6 GRM7 ATL1 SLC12A2 ASXL3 VPS13A GTF2IRD2 MACF1 STAG2 GABRA1 GABRA2 GABRA5 | 9.24e-04 | 1151 | 42 | 19 | HP:0001276 |
| HumanPheno | Spasticity | NPC1 NHLRC1 FOXRED1 SZT2 CAMK2B GRIN2A GRIN2B ZSWIM6 GRM7 ATL1 SLC12A2 ASXL3 VPS13A GTF2IRD2 MACF1 STAG2 GABRA1 GABRA2 GABRA5 | 9.24e-04 | 1151 | 42 | 19 | HP:0001257 |
| HumanPheno | Interictal epileptiform activity | 9.35e-04 | 319 | 42 | 9 | HP:0011182 | |
| HumanPheno | Atonic seizure | 9.53e-04 | 94 | 42 | 5 | HP:0010819 | |
| HumanPheno | Non-motor seizure | 9.92e-04 | 197 | 42 | 7 | HP:0033259 | |
| HumanPheno | Dyskinesia | 1.02e-03 | 198 | 42 | 7 | HP:0100660 | |
| HumanPheno | Interictal EEG abnormality | 1.07e-03 | 325 | 42 | 9 | HP:0025373 | |
| MousePheno | abnormal GABA-mediated receptor currents | 1.81e-07 | 18 | 106 | 5 | MP:0004008 | |
| MousePheno | abnormal synaptic transmission | NPC1 NHLRC1 TNC GPR37 CAMK2B DUOX2 GRIN2A GRIN2B GRM2 GRM5 GRM6 GRM7 FMNL2 NRXN3 NRXN1 NRXN2 VPS13A BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 NIN | 1.12e-06 | 1070 | 106 | 24 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | NPC1 NHLRC1 TNC GPR37 CAMK2B DUOX2 GRIN2A GRIN2B GRM2 GRM5 GRM6 GRM7 FMNL2 NRXN3 NRXN1 NRXN2 VPS13A BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 NIN | 1.24e-06 | 1076 | 106 | 24 | MP:0021009 |
| MousePheno | impaired coordination | NPC1 KLHL1 WFS1 GPR37 CAMK2B GRIN2A GRIN2B ZSWIM6 GRM2 GRM7 LNPEP VPS13A LRP2 GABRA1 OTOG | 3.05e-06 | 478 | 106 | 15 | MP:0001405 |
| MousePheno | abnormal CNS synaptic transmission | NPC1 NHLRC1 TNC GPR37 CAMK2B DUOX2 GRIN2A GRIN2B GRM2 GRM5 GRM7 FMNL2 NRXN3 NRXN1 NRXN2 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 NIN | 3.69e-06 | 985 | 106 | 22 | MP:0002206 |
| MousePheno | abnormal behavioral response to xenobiotic | NHLRC1 SZT2 WFS1 ZSWIM6 GRM2 GRM5 GRM7 BSN GABRA1 GABRA2 GABRA4 GABRA5 | 3.78e-06 | 309 | 106 | 12 | MP:0009745 |
| MousePheno | abnormal motor coordination/balance | NPC1 KLHL1 WFS1 TNC GPR37 CAMK2B GRIN2A GRIN2B ZSWIM6 GRM2 GRM5 GRM7 SLC12A2 LNPEP VPS13A LRP2 CAMTA1 BSN GABRA1 OTOG | 7.59e-06 | 873 | 106 | 20 | MP:0001516 |
| MousePheno | increased locomotor activity | 8.18e-06 | 178 | 106 | 9 | MP:0031391 | |
| MousePheno | abnormal anxiety-related response | NPC1 NHLRC1 WFS1 TNC CAMK2B DUSP1 GRIN2A GRIN2B ZSWIM6 GRM2 GRM3 GRM7 TRANK1 NRXN2 LNPEP NAV2 GABRA2 NIN | 1.04e-05 | 740 | 106 | 18 | MP:0001362 |
| MousePheno | abnormal fear/anxiety-related behavior | NPC1 NHLRC1 WFS1 TNC CAMK2B DUSP1 DUOX2 GRIN2A GRIN2B ZSWIM6 GRM2 GRM3 GRM7 TRANK1 NRXN2 LNPEP NAV2 GABRA1 GABRA2 NIN | 1.62e-05 | 919 | 106 | 20 | MP:0002065 |
| MousePheno | abnormal cochlear labyrinth morphology | 7.34e-05 | 235 | 106 | 9 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 7.34e-05 | 235 | 106 | 9 | MP:0003169 | |
| MousePheno | abnormal cochlea morphology | 1.11e-04 | 248 | 106 | 9 | MP:0000031 | |
| MousePheno | decreased anxiety-related response | NPC1 NHLRC1 TNC CAMK2B DUSP1 GRIN2A GRIN2B ZSWIM6 GRM7 TRANK1 NAV2 NIN | 1.58e-04 | 452 | 106 | 12 | MP:0001364 |
| MousePheno | hyperactivity | NPC1 NHLRC1 HIP1 WFS1 TNC CAMK2B GRIN2B ZSWIM6 GRM2 GRM6 GRM7 CCKAR SLC12A2 NRXN2 MPZL3 NAV2 GABRA2 OTOG GABRA3 GABRA5 NIN | 1.64e-04 | 1172 | 106 | 21 | MP:0001399 |
| MousePheno | abnormal membranous labyrinth morphology | 1.68e-04 | 262 | 106 | 9 | MP:0000035 | |
| MousePheno | abnormal inhibitory postsynaptic currents | 1.87e-04 | 70 | 106 | 5 | MP:0002945 | |
| MousePheno | increased susceptibility to pharmacologically induced seizures | 2.61e-04 | 117 | 106 | 6 | MP:0002906 | |
| MousePheno | increased susceptibility to induction of seizure by inducing agent | 2.73e-04 | 118 | 106 | 6 | MP:0012349 | |
| MousePheno | abnormal long-term potentiation | 2.75e-04 | 221 | 106 | 8 | MP:0002207 | |
| MousePheno | abnormal cocaine consumption | 3.38e-04 | 4 | 106 | 2 | MP:0002556 | |
| MousePheno | abnormal social/conspecific interaction behavior | WFS1 CAMK2B MC5R GRIN2B GRM7 SLC12A2 NRXN1 NRXN2 MPZL3 VPS13A GABRA1 | 3.45e-04 | 421 | 106 | 11 | MP:0002557 |
| MousePheno | abnormal cochlear inner hair cell morphology | 3.57e-04 | 124 | 106 | 6 | MP:0004393 | |
| MousePheno | impaired behavioral response to xenobiotic | 4.14e-04 | 83 | 106 | 5 | MP:0009747 | |
| MousePheno | increased or absent threshold for auditory brainstem response | 4.26e-04 | 236 | 106 | 8 | MP:0011967 | |
| MousePheno | abnormal inner ear morphology | 4.89e-04 | 303 | 106 | 9 | MP:0000026 | |
| Domain | GABAAa_rcpt | 8.36e-14 | 6 | 126 | 6 | IPR001390 | |
| Domain | GPCR_3_mtglu_rcpt | 7.11e-10 | 8 | 126 | 5 | IPR000162 | |
| Domain | ANF_lig-bd_rcpt | 4.68e-09 | 37 | 126 | 7 | IPR001828 | |
| Domain | ANF_receptor | 4.68e-09 | 37 | 126 | 7 | PF01094 | |
| Domain | Peripla_BP_I | 6.91e-09 | 39 | 126 | 7 | IPR028082 | |
| Domain | GABAA/Glycine_rcpt | 7.68e-09 | 23 | 126 | 6 | IPR006028 | |
| Domain | NCD3G | 1.59e-08 | 13 | 126 | 5 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.59e-08 | 13 | 126 | 5 | IPR011500 | |
| Domain | GPCR_3_CS | 2.46e-08 | 14 | 126 | 5 | IPR017979 | |
| Domain | GPCR_3 | 2.41e-07 | 21 | 126 | 5 | IPR000337 | |
| Domain | 7tm_3 | 3.10e-07 | 22 | 126 | 5 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 3.10e-07 | 22 | 126 | 5 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 3.10e-07 | 22 | 126 | 5 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 3.10e-07 | 22 | 126 | 5 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 3.10e-07 | 22 | 126 | 5 | PS50259 | |
| Domain | GPCR_3_C | 3.10e-07 | 22 | 126 | 5 | IPR017978 | |
| Domain | Neurotransmitter_ion_chnl_CS | 5.49e-07 | 45 | 126 | 6 | IPR018000 | |
| Domain | Neur_chan_memb | 6.28e-07 | 46 | 126 | 6 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 7.16e-07 | 47 | 126 | 6 | IPR006029 | |
| Domain | - | 7.16e-07 | 47 | 126 | 6 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 7.16e-07 | 47 | 126 | 6 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 7.16e-07 | 47 | 126 | 6 | PS00236 | |
| Domain | Neur_channel | 7.16e-07 | 47 | 126 | 6 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 7.16e-07 | 47 | 126 | 6 | IPR006202 | |
| Domain | Syndecan | 1.03e-05 | 7 | 126 | 3 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.03e-05 | 7 | 126 | 3 | IPR027789 | |
| Domain | SUGAR_TRANSPORT_1 | 1.89e-05 | 24 | 126 | 4 | PS00216 | |
| Domain | NPC1_N | 4.52e-05 | 2 | 126 | 2 | IPR032190 | |
| Domain | NP_C_type | 4.52e-05 | 2 | 126 | 2 | IPR004765 | |
| Domain | NPC1_N | 4.52e-05 | 2 | 126 | 2 | PF16414 | |
| Domain | Sugar_transporter_CS | 6.13e-05 | 32 | 126 | 4 | IPR005829 | |
| Domain | TIL_dom | 1.03e-04 | 14 | 126 | 3 | IPR002919 | |
| Domain | Neurexin-like | 1.03e-04 | 14 | 126 | 3 | IPR003585 | |
| Domain | 4.1m | 1.03e-04 | 14 | 126 | 3 | SM00294 | |
| Domain | LAM_G_DOMAIN | 1.22e-04 | 38 | 126 | 4 | PS50025 | |
| Domain | RFX1_trans_act | 1.35e-04 | 3 | 126 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 1.35e-04 | 3 | 126 | 2 | PF04589 | |
| Domain | NMDAR2_C | 1.35e-04 | 3 | 126 | 2 | PF10565 | |
| Domain | NMDAR2_C | 1.35e-04 | 3 | 126 | 2 | IPR018884 | |
| Domain | Laminin_G_2 | 1.50e-04 | 40 | 126 | 4 | PF02210 | |
| Domain | EGF | 2.13e-04 | 126 | 126 | 6 | PF00008 | |
| Domain | LamG | 2.18e-04 | 44 | 126 | 4 | SM00282 | |
| Domain | - | 2.69e-04 | 4 | 126 | 2 | 3.90.1460.10 | |
| Domain | Glut_rich_SH3-bd | 2.69e-04 | 4 | 126 | 2 | IPR006993 | |
| Domain | SH3BGR | 2.69e-04 | 4 | 126 | 2 | PF04908 | |
| Domain | GTF2I | 2.69e-04 | 4 | 126 | 2 | PS51139 | |
| Domain | GTF2I | 2.69e-04 | 4 | 126 | 2 | PF02946 | |
| Domain | GTF2I | 2.69e-04 | 4 | 126 | 2 | IPR004212 | |
| Domain | EGF-like_dom | 2.90e-04 | 249 | 126 | 8 | IPR000742 | |
| Domain | Sterol-sensing | 4.46e-04 | 5 | 126 | 2 | PF12349 | |
| Domain | Laminin_G | 6.32e-04 | 58 | 126 | 4 | IPR001791 | |
| Domain | EGF | 1.09e-03 | 235 | 126 | 7 | SM00181 | |
| Domain | EGF_3 | 1.09e-03 | 235 | 126 | 7 | PS50026 | |
| Domain | Orgcat_transp/SVOP | 1.58e-03 | 9 | 126 | 2 | IPR004749 | |
| Domain | RFX_DNA_binding | 1.58e-03 | 9 | 126 | 2 | PF02257 | |
| Domain | Ptc/Disp | 1.58e-03 | 9 | 126 | 2 | IPR003392 | |
| Domain | DNA-bd_RFX | 1.58e-03 | 9 | 126 | 2 | IPR003150 | |
| Domain | Patched | 1.58e-03 | 9 | 126 | 2 | PF02460 | |
| Domain | RFX_DBD | 1.58e-03 | 9 | 126 | 2 | PS51526 | |
| Domain | EGF_1 | 1.73e-03 | 255 | 126 | 7 | PS00022 | |
| Domain | MFS_sugar_transport-like | 1.82e-03 | 36 | 126 | 3 | IPR005828 | |
| Domain | Sugar_tr | 1.82e-03 | 36 | 126 | 3 | PF00083 | |
| Domain | SLC26A | 1.96e-03 | 10 | 126 | 2 | PS01130 | |
| Domain | EGF-like_CS | 1.98e-03 | 261 | 126 | 7 | IPR013032 | |
| Domain | MFS_dom | 2.15e-03 | 134 | 126 | 5 | IPR020846 | |
| Domain | EGF_2 | 2.15e-03 | 265 | 126 | 7 | PS01186 | |
| Domain | STAS | 2.39e-03 | 11 | 126 | 2 | PS50801 | |
| Domain | STAS | 2.39e-03 | 11 | 126 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 2.39e-03 | 11 | 126 | 2 | IPR001902 | |
| Domain | STAS_dom | 2.39e-03 | 11 | 126 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 2.39e-03 | 11 | 126 | 2 | IPR011547 | |
| Domain | - | 2.39e-03 | 11 | 126 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 2.39e-03 | 11 | 126 | 2 | PF00916 | |
| Domain | C8 | 2.85e-03 | 12 | 126 | 2 | PF08742 | |
| Domain | TIL | 2.85e-03 | 12 | 126 | 2 | PF01826 | |
| Domain | SSD | 3.35e-03 | 13 | 126 | 2 | IPR000731 | |
| Domain | SSD | 3.35e-03 | 13 | 126 | 2 | PS50156 | |
| Domain | Unchr_dom_Cys-rich | 3.35e-03 | 13 | 126 | 2 | IPR014853 | |
| Domain | C8 | 3.35e-03 | 13 | 126 | 2 | SM00832 | |
| Domain | - | 3.64e-03 | 218 | 126 | 6 | 1.10.10.10 | |
| Domain | - | 3.92e-03 | 95 | 126 | 4 | 2.60.120.200 | |
| Domain | Growth_fac_rcpt_ | 4.14e-03 | 156 | 126 | 5 | IPR009030 | |
| Domain | ASX_HYDROXYL | 4.70e-03 | 100 | 126 | 4 | PS00010 | |
| Domain | VWF_type-D | 5.09e-03 | 16 | 126 | 2 | IPR001846 | |
| Domain | VWFD | 5.09e-03 | 16 | 126 | 2 | PS51233 | |
| Domain | VWD | 5.09e-03 | 16 | 126 | 2 | SM00216 | |
| Domain | VWD | 5.09e-03 | 16 | 126 | 2 | PF00094 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.78e-03 | 106 | 126 | 4 | IPR000152 | |
| Domain | WHTH_DNA-bd_dom | 6.02e-03 | 242 | 126 | 6 | IPR011991 | |
| Domain | MFS | 6.17e-03 | 108 | 126 | 4 | PS50850 | |
| Domain | Lig_chan-Glu_bd | 6.44e-03 | 18 | 126 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 6.44e-03 | 18 | 126 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.44e-03 | 18 | 126 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 6.44e-03 | 18 | 126 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.44e-03 | 18 | 126 | 2 | IPR001508 | |
| Domain | Lig_chan | 6.44e-03 | 18 | 126 | 2 | PF00060 | |
| Domain | PBPe | 6.44e-03 | 18 | 126 | 2 | SM00079 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 9.61e-12 | 9 | 101 | 6 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.39e-11 | 10 | 101 | 6 | M477 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | MC5R GRIN2A GRIN2B GRM2 GRM3 GRM5 GRM6 GRM7 NPFFR1 CCKAR GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 8.75e-11 | 272 | 101 | 16 | M13380 |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.18e-09 | 10 | 101 | 5 | MM1401 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GRIN2A GRIN2B GRM2 GRM3 GRM5 GRM6 GRM7 NRXN3 NRXN1 NRXN2 SLC25A39 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 6.87e-09 | 367 | 101 | 16 | M48346 |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 4.85e-08 | 15 | 101 | 5 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 4.85e-08 | 15 | 101 | 5 | MM15845 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 7.41e-08 | 31 | 101 | 6 | M39369 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.10e-07 | 33 | 101 | 6 | M39875 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 2.67e-07 | 38 | 101 | 6 | M39854 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 2.83e-06 | 56 | 101 | 6 | M27616 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 4.26e-06 | 60 | 101 | 6 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 4.26e-06 | 60 | 101 | 6 | M976 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CAMK2B GRIN2A GRM5 NRXN3 NRXN1 NRXN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.77e-06 | 335 | 101 | 12 | MM14503 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 6.21e-06 | 37 | 101 | 5 | MM15067 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CAMK2B GRIN2A GRIN2B GRM5 NRXN3 NRXN1 NRXN2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.24e-06 | 411 | 101 | 13 | M735 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 8.11e-06 | 39 | 101 | 5 | M793 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 8.85e-06 | 144 | 101 | 8 | MM14501 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | CAMK2B GRIN2A GRIN2B GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.60e-05 | 205 | 101 | 9 | M752 |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 2.28e-05 | 119 | 101 | 7 | M48309 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.68e-05 | 87 | 101 | 6 | M27617 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 3.84e-05 | 27 | 101 | 4 | M45550 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 7.65e-05 | 32 | 101 | 4 | MM15326 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.16e-04 | 67 | 101 | 5 | MM15327 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.35e-04 | 211 | 101 | 8 | MM14502 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | CAMK2B GRIN2A GRIN2B GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.36e-04 | 270 | 101 | 9 | M15514 |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.74e-04 | 73 | 101 | 5 | MM16641 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 2.69e-04 | 18 | 101 | 3 | M48098 | |
| Pathway | WP_GPCRS_ORPHAN | 3.18e-04 | 19 | 101 | 3 | MM15991 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.32e-04 | 21 | 101 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 4.32e-04 | 21 | 101 | 3 | M27944 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 5.01e-04 | 5 | 101 | 2 | M47667 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 5.04e-04 | 140 | 101 | 6 | M42572 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 5.70e-04 | 23 | 101 | 3 | M27949 | |
| Pathway | WP_GPCRS_NONODORANT | 6.43e-04 | 266 | 101 | 8 | MM15843 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 7.48e-04 | 6 | 101 | 2 | M47668 | |
| Pathway | REACTOME_ORGANIC_CATION_TRANSPORT | 1.38e-03 | 8 | 101 | 2 | MM15191 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.58e-03 | 70 | 101 | 4 | M3115 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 1.76e-03 | 121 | 101 | 5 | M39804 | |
| Pubmed | GRIN2A GRIN2B GRM2 GRM3 GRM5 GRM6 GRM7 CCKAR GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.32e-20 | 81 | 127 | 14 | 22723691 | |
| Pubmed | 2.10e-15 | 6 | 127 | 6 | 20457185 | ||
| Pubmed | GRIN2A GRIN2B GRM2 GRM3 GRM5 GRM6 GRM7 CCKAR NRXN3 NRXN1 NRXN2 GABRA1 GABRA2 GABRA3 GABRA5 GABRA6 | 2.18e-14 | 300 | 127 | 16 | 19086053 | |
| Pubmed | 6.86e-14 | 45 | 127 | 9 | 25979088 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 4.37e-13 | 10 | 127 | 6 | 9069281 | |
| Pubmed | 8.16e-13 | 21 | 127 | 7 | 25708312 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 9.58e-13 | 11 | 127 | 6 | 9924185 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 2.41e-12 | 24 | 127 | 7 | 35746896 | |
| Pubmed | 3.54e-12 | 13 | 127 | 6 | 22569571 | ||
| Pubmed | 3.54e-12 | 13 | 127 | 6 | 22640814 | ||
| Pubmed | 1.25e-11 | 7 | 127 | 5 | 9920659 | ||
| Pubmed | 3.33e-11 | 8 | 127 | 5 | 8175718 | ||
| Pubmed | 3.77e-11 | 18 | 127 | 6 | 19078961 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | MC5R GRIN2A GRIN2B GRM5 CCKAR GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.81e-11 | 182 | 127 | 11 | 20468064 |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 1.38e-10 | 67 | 127 | 8 | 16987237 | |
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 25865415 | ||
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 2.72e-10 | 11 | 127 | 5 | 38894703 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 8.45e-10 | 5 | 127 | 4 | 30104684 | |
| Pubmed | 1.17e-09 | 14 | 127 | 5 | 22768092 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 2.53e-09 | 6 | 127 | 4 | 15033447 | |
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 7560270 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 5.88e-09 | 7 | 127 | 4 | 20843900 | |
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 17021187 | ||
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 35228700 | ||
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 16101898 | ||
| Pubmed | EP400 SZT2 USP28 UFL1 UBE2O TRANK1 NRXN3 NUP155 NRXN2 AMOT NAV2 DEPDC5 BSN NIN | 9.64e-09 | 529 | 127 | 14 | 14621295 | |
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 1.17e-08 | 8 | 127 | 4 | 18185516 | |
| Pubmed | 1.17e-08 | 8 | 127 | 4 | 11528422 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.32e-08 | 118 | 127 | 8 | 19156168 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.71e-08 | 79 | 127 | 7 | 12679517 | |
| Pubmed | 3.01e-08 | 25 | 127 | 5 | 31665922 | ||
| Pubmed | 3.50e-08 | 10 | 127 | 4 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 3.50e-08 | 10 | 127 | 4 | 21789198 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 38891114 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16406382 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 31005376 | ||
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 4.76e-08 | 3 | 127 | 3 | 26446217 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 15017002 | ||
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 4.76e-08 | 3 | 127 | 3 | 11944992 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 4.76e-08 | 3 | 127 | 3 | 17035546 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 4.76e-08 | 3 | 127 | 3 | 25423136 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 4.76e-08 | 3 | 127 | 3 | 34133920 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16835366 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21521618 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 30858964 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24949866 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 28013231 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 15304513 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 31812984 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 4.76e-08 | 3 | 127 | 3 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 4.76e-08 | 3 | 127 | 3 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 4.76e-08 | 3 | 127 | 3 | 29045040 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 38571813 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 35173587 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 1356407 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 17329427 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 4.76e-08 | 3 | 127 | 3 | 7722633 | |
| Pubmed | 9.44e-08 | 31 | 127 | 5 | 19736351 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | SZT2 MUC16 CEACAM6 ABCC5 DUOX2 ZSWIM6 FMNL2 FAT1 TRANK1 ASXL3 SERPINE1 VPS13A NAV2 | 1.29e-07 | 552 | 127 | 13 | 10737800 |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 29079293 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 32706374 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 8786425 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 17347997 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 26518133 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 1.90e-07 | 4 | 127 | 3 | 33888718 | |
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 1.90e-07 | 4 | 127 | 3 | 14983056 | |
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 1.90e-07 | 4 | 127 | 3 | 19842164 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 25080596 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 1.90e-07 | 4 | 127 | 3 | 32134527 | |
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 1.90e-07 | 4 | 127 | 3 | 20692323 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 1.90e-07 | 4 | 127 | 3 | 18821008 | |
| Pubmed | 2.46e-07 | 116 | 127 | 7 | 21102463 | ||
| Pubmed | 2.73e-07 | 38 | 127 | 5 | 25613138 | ||
| Pubmed | 2.98e-07 | 16 | 127 | 4 | 30466882 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 36709330 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 12388627 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 20537373 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 4.73e-07 | 5 | 127 | 3 | 18923512 | |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 9223334 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 28472659 | ||
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 4.99e-07 | 18 | 127 | 4 | 28864826 | |
| Pubmed | 4.99e-07 | 18 | 127 | 4 | 18985723 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 5.33e-07 | 130 | 127 | 7 | 19874574 | |
| Pubmed | WFS1 CAMK2B SH3BGRL PSMD12 GRIN2A GRIN2B EDC4 GRM5 SLC30A1 ATL1 UBE2O NRXN1 MACF1 BSN GABRA1 GABRA2 GABRA5 | 9.18e-07 | 1139 | 127 | 17 | 36417873 | |
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 30683685 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 21751815 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 9.43e-07 | 6 | 127 | 3 | 12827191 | |
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 20412381 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 9.43e-07 | 6 | 127 | 3 | 8576240 | |
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 20848605 | ||
| Pubmed | 1.18e-06 | 22 | 127 | 4 | 35245678 | ||
| Pubmed | 1.18e-06 | 22 | 127 | 4 | 38736483 | ||
| Pubmed | 1.36e-06 | 52 | 127 | 5 | 19328558 | ||
| Pubmed | HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. | 1.65e-06 | 7 | 127 | 3 | 11606043 | |
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 12147342 | ||
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 12775422 | ||
| Pubmed | 1.65e-06 | 7 | 127 | 3 | 16080114 | ||
| Interaction | GABRA5 interactions | 2.31e-06 | 5 | 125 | 3 | int:GABRA5 | |
| Cytoband | 5q34 | 9.67e-05 | 32 | 127 | 3 | 5q34 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.00e-10 | 8 | 83 | 5 | 281 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 2.01e-10 | 19 | 83 | 6 | 563 | |
| GeneFamily | Solute carriers | SLC22A23 SLC26A5 SLC30A1 SLC12A2 SLC35F3 SLC15A2 SLC26A7 SLC25A39 SLC35D3 SLC22A4 SLC22A5 | 1.86e-06 | 395 | 83 | 11 | 752 |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 4.31e-04 | 7 | 83 | 2 | 1201 | |
| GeneFamily | Regulatory factor X family | 5.73e-04 | 8 | 83 | 2 | 1153 | |
| GeneFamily | CD molecules|Mucins | 4.13e-03 | 21 | 83 | 2 | 648 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPR155 CAMK2B LRRC49 MUC19 ABCC5 GRM3 GRM5 GRM7 FMNL2 ATL1 NRXN3 NRXN1 NRXN2 ASXL3 SLC22A4 CAMTA1 BSN GABRA1 GABRA2 | 1.62e-06 | 1106 | 127 | 19 | M39071 |
| Coexpression | GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN | 6.16e-06 | 200 | 127 | 8 | M8846 | |
| Coexpression | GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN | 6.16e-06 | 200 | 127 | 8 | M4343 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | GPR155 DSG2 WFS1 MUC19 GRIN2A FMNL2 SORCS1 FAT1 APPL2 SLC15A2 LRP2 ECHDC2 | 2.37e-05 | 574 | 127 | 12 | M39056 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | KLHL1 CAMK2B INSRR SLC26A5 DUOX2 GRM6 GRM7 SORCS1 NRXN1 SLC35F3 SLC35D3 LRP2 NAV2 GPC5 GABRA2 GABRA4 NIN | 2.80e-05 | 1115 | 127 | 17 | M10371 |
| Coexpression | CRX_NRL_DN.V1_DN | 3.68e-05 | 127 | 127 | 6 | M2794 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GPR155 KLHL1 CAMK2B MUC19 GRM5 GRM7 SORCS1 NRXN3 NRXN1 NRXN2 ASXL3 BSN GABRA1 | 3.84e-05 | 703 | 127 | 13 | M39070 |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 5.42e-05 | 199 | 127 | 7 | M5357 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_DN | 5.59e-05 | 200 | 127 | 7 | M3315 | |
| CoexpressionAtlas | cerebral cortex | KLHL1 GPR37 CAMK2B GRIN2A GRIN2B GRM2 GRM3 GRM5 GRM7 FMNL2 ATL1 SORCS1 NRXN3 NRXN1 SLC35F3 NRXN2 GPC5 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 5.90e-06 | 1428 | 122 | 23 | cerebral cortex |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | DUSP1 GRM3 GRM7 CCKAR SORCS1 SLC35F3 SLC26A7 ASXL3 SLC35D3 SERPINE1 GABRA1 GABRA4 | 6.17e-06 | 424 | 122 | 12 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_500 | 9.73e-06 | 129 | 122 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | GRM3 GRM7 CCKAR ATL1 SORCS1 NRXN3 SLC35F3 SLC26A7 SERPINE1 GABRA1 | 1.14e-05 | 307 | 122 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.60e-05 | 193 | 122 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-vs-M_top280_280 | GPR155 ZNF143 DSG2 SLC22A23 GRM3 ASXL3 SERPINE1 CAMTA1 GABRA1 | 1.97e-05 | 260 | 122 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-vs-M |
| CoexpressionAtlas | BM Top 100 - frontal lobe | 5.93e-05 | 72 | 122 | 5 | BM Top 100 - frontal lobe | |
| CoexpressionAtlas | BM Top 100 - temporal lobe | 6.77e-05 | 74 | 122 | 5 | BM Top 100 - temporal lobe | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | SH3BGRL DUSP1 GRM3 GRM7 CCKAR ATL1 SORCS1 NRXN3 SLC35F3 SLC26A7 ASXL3 SLC35D3 SERPINE1 GABRA1 GABRA4 | 8.07e-05 | 827 | 122 | 15 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | GPR155 ZNF143 DSG2 TNC SLC22A23 GRM3 SORCS1 SLC15A2 SLC26A7 ASXL3 SLC35D3 SERPINE1 CAMTA1 GABRA1 GABRA4 | 1.09e-04 | 850 | 122 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | GPR155 TNC GRM7 SSPN TRPM5 APPL2 SLC12A2 SLC35F3 SLC15A2 NAV2 SFXN2 DEPDC5 MGA GABRA4 | 1.97e-04 | 797 | 122 | 14 | gudmap_developingGonad_P2_epididymis_1000 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CAMK2B GRIN2A GRIN2B GRM2 GRM5 TRANK1 SLC35F3 PLCL2 BSN GABRA1 GABRA4 GABRA5 | 4.35e-13 | 195 | 127 | 12 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CAMK2B GRIN2A GRIN2B GRM2 GRM5 TRANK1 PLCL2 BSN GABRA1 GABRA5 | 2.26e-10 | 193 | 127 | 10 | 461919ab422bc9d1fcff7a3a4757c75239041d7e |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CAMK2B GRIN2A GRIN2B GRM2 GRM5 TRANK1 PLCL2 BSN GABRA1 GABRA5 | 2.26e-10 | 193 | 127 | 10 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.47e-09 | 192 | 127 | 9 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-08 | 184 | 127 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-08 | 184 | 127 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-08 | 184 | 127 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.93e-08 | 191 | 127 | 8 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.67e-08 | 196 | 127 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-07 | 197 | 127 | 8 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-07 | 198 | 127 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-07 | 198 | 127 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.13e-07 | 200 | 127 | 8 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-07 | 174 | 127 | 7 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.08e-07 | 178 | 127 | 7 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.03e-07 | 181 | 127 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 184 | 127 | 7 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 184 | 127 | 7 | c3b848e1438a84b3fac8a4e40f3db478cc84d970 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 185 | 127 | 7 | 30263c558ee331e0879abcf8b4c2427ff05f9fe7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 185 | 127 | 7 | 1b000ca11970db8f347eb97ff44605d562aea70a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 186 | 127 | 7 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Early_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 186 | 127 | 7 | ae4b6ecfc1850c0a01a11b9dd9718880f2a24fe0 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.16e-06 | 188 | 127 | 7 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 189 | 127 | 7 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 189 | 127 | 7 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 190 | 127 | 7 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-06 | 190 | 127 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.29e-06 | 191 | 127 | 7 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.29e-06 | 191 | 127 | 7 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 193 | 127 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.39e-06 | 193 | 127 | 7 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 193 | 127 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 193 | 127 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.44e-06 | 194 | 127 | 7 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.44e-06 | 194 | 127 | 7 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.44e-06 | 194 | 127 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 195 | 127 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 195 | 127 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 1.59e-06 | 197 | 127 | 7 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-06 | 198 | 127 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.64e-06 | 198 | 127 | 7 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-06 | 200 | 127 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-06 | 200 | 127 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 127 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-06 | 200 | 127 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-06 | 138 | 127 | 6 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.97e-06 | 139 | 127 | 6 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.97e-06 | 139 | 127 | 6 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-06 | 144 | 127 | 6 | 57d2846ec26d4490ec11c171af447b17a729437e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 148 | 127 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.61e-06 | 150 | 127 | 6 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.44e-06 | 159 | 127 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 169 | 127 | 6 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.01e-05 | 172 | 127 | 6 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.04e-05 | 173 | 127 | 6 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 176 | 127 | 6 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.15e-05 | 176 | 127 | 6 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 177 | 127 | 6 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-05 | 179 | 127 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 181 | 127 | 6 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 182 | 127 | 6 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 182 | 127 | 6 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.43e-05 | 183 | 127 | 6 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.48e-05 | 184 | 127 | 6 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.53e-05 | 185 | 127 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 1.53e-05 | 185 | 127 | 6 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 185 | 127 | 6 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 186 | 127 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.57e-05 | 186 | 127 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 186 | 127 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.62e-05 | 187 | 127 | 6 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 187 | 127 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 188 | 127 | 6 | 068b761a7b6778bc6d6c776b5f09094aac87477e | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 188 | 127 | 6 | c95134245dab9057eb1f9b54acb371470f9c8b86 | |
| ToppCell | droplet-Lung-21m-Epithelial-alveolar_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 188 | 127 | 6 | 3ee321a74f04eb0982c7b4977426946b0ae6e5a9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-05 | 188 | 127 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 189 | 127 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.77e-05 | 190 | 127 | 6 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.77e-05 | 190 | 127 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-migDC|GI_small-bowel / Manually curated celltypes from each tissue | 1.77e-05 | 190 | 127 | 6 | e9b2c201d07f0cb87fa60005251c9e1663e246ed | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 191 | 127 | 6 | feec8617678b778475747ad406c80231e07fd6f7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 192 | 127 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 1.94e-05 | 193 | 127 | 6 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 1.94e-05 | 193 | 127 | 6 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 193 | 127 | 6 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | CTRL-Epithelial-Epithelial_cell|CTRL / Disease state, Lineage and Cell class | 1.99e-05 | 194 | 127 | 6 | 2bc4deaf2a01a39809fc323962fce4286835209c | |
| ToppCell | CTRL-Epithelial|CTRL / Disease state, Lineage and Cell class | 1.99e-05 | 194 | 127 | 6 | 49dcb31427f370692308f939e23992925708abb7 | |
| ToppCell | droplet-Mammary_Gland-nan-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 195 | 127 | 6 | c771ac1db8bd5f3a80bd3484094a58c28983f97b | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 195 | 127 | 6 | 18220efbd2d6ce6aa7501744fe430b6b46f2fc30 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-05 | 195 | 127 | 6 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 195 | 127 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 116 | 127 | 5 | cf4e3c34570f57502ec524881d351ef8e47976d2 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-05 | 196 | 127 | 6 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.11e-05 | 196 | 127 | 6 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.17e-05 | 197 | 127 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.17e-05 | 197 | 127 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 198 | 127 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| Computational | Genes in the cancer module 141. | 1.05e-07 | 16 | 84 | 5 | MODULE_141 | |
| Computational | Genes in the cancer module 396. | 1.64e-06 | 12 | 84 | 4 | MODULE_396 | |
| Computational | Neurotransmitter (GABA) receptor. | 1.96e-04 | 15 | 84 | 3 | MODULE_215 | |
| Computational | Vesicular transport / synapse genes. | 4.40e-04 | 82 | 84 | 5 | MODULE_274 | |
| Drug | felbamate | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.79e-18 | 70 | 126 | 14 | CID000003331 |
| Drug | acamprosate | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.91e-16 | 74 | 126 | 13 | CID000071158 |
| Drug | AP-5 | CAMK2B GRIN2A GRIN2B ZSWIM6 GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 4.64e-16 | 128 | 126 | 15 | CID000001216 |
| Drug | cyclothiazide | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.48e-16 | 103 | 126 | 14 | CID000002910 |
| Drug | AP-7 | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 1.02e-15 | 63 | 126 | 12 | CID000003122 |
| Drug | D-N-Q | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 1.09e-15 | 84 | 126 | 13 | CID000003140 |
| Drug | IPSP | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 1.75e-15 | 87 | 126 | 13 | CID000022083 |
| Drug | nimodipine | GRIN2A GRIN2B GRINA GRM2 PKD1L3 GRM3 GRM5 SLC30A1 GRM6 GRM7 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 3.09e-15 | 145 | 126 | 15 | CID000004497 |
| Drug | baclofen | GRIN2A GRIN2B GRINA GRM2 PKD1L3 GRM3 GRM5 GRM6 GRM7 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.02e-14 | 191 | 126 | 16 | CID000002284 |
| Drug | AC1NNRU4 | 1.82e-14 | 41 | 126 | 10 | CID005126051 | |
| Drug | Meprobamate | 2.55e-14 | 6 | 126 | 6 | DB00371 | |
| Drug | DNQX | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 3.36e-14 | 83 | 126 | 12 | CID003899541 |
| Drug | riluzole | GRIN2A GRIN2B GRINA GRM2 PKD1L3 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.74e-14 | 174 | 126 | 15 | CID000005070 |
| Drug | DE gel | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 BSN GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 5.88e-14 | 143 | 126 | 14 | CID000008146 |
| Drug | L-quisqualic acid | KNTC1 GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.84e-14 | 180 | 126 | 15 | CID000001209 |
| Drug | NBQX | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 9.20e-14 | 90 | 126 | 12 | CID003272523 |
| Drug | kynurenic acid | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 1.60e-13 | 122 | 126 | 13 | CID000003845 |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 4.80e-13 | 24 | 126 | 8 | CID003645780 | |
| Drug | gabapentin | GRIN2A GRIN2B GRINA GRM2 PKD1L3 GRM3 GRM5 GRM6 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 6.00e-13 | 169 | 126 | 14 | CID000003446 |
| Drug | MK-801 | TNC CAMK2B GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GPR119 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.07e-13 | 296 | 126 | 17 | CID000001207 |
| Drug | AC1NQH9B | 1.01e-12 | 26 | 126 | 8 | CID005221504 | |
| Drug | AC1Q3ZOL | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 NPFFR1 SLC12A2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.09e-12 | 258 | 126 | 16 | CID000002376 |
| Drug | AC1L1B1W | GRIN2A GRIN2B GRINA GRM3 SLC12A2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.26e-12 | 84 | 126 | 11 | CID000001248 |
| Drug | picrotoxin | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.54e-12 | 181 | 126 | 14 | CID000031304 |
| Drug | LY341495 | 1.75e-12 | 43 | 126 | 9 | CID006324636 | |
| Drug | chlormethiazole | 1.99e-12 | 28 | 126 | 8 | CID000010783 | |
| Drug | Ethchlorvynol | 2.11e-12 | 9 | 126 | 6 | DB00189 | |
| Drug | saclofen | 2.19e-12 | 44 | 126 | 9 | CID000122150 | |
| Drug | pregnanolone | NPC1 GRIN2A GRIN2B GRINA NPC1L1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.75e-12 | 90 | 126 | 11 | CID000031402 |
| Drug | NO-711 | GRM2 GRM5 GRM6 SLC22A5 BSN GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 3.04e-12 | 66 | 126 | 10 | CID000004515 |
| Drug | oriens | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 3.29e-12 | 154 | 126 | 13 | CID000161645 |
| Drug | Secobarbital | 5.25e-12 | 10 | 126 | 6 | DB00418 | |
| Drug | Chlordiazepoxide | 5.25e-12 | 10 | 126 | 6 | DB00475 | |
| Drug | Metharbital | 5.25e-12 | 10 | 126 | 6 | DB00463 | |
| Drug | Pentobarbital | 5.25e-12 | 10 | 126 | 6 | DB00312 | |
| Drug | Talbutal | 5.25e-12 | 10 | 126 | 6 | DB00306 | |
| Drug | Clobazam | 5.25e-12 | 10 | 126 | 6 | DB00349 | |
| Drug | Butalbital | 5.25e-12 | 10 | 126 | 6 | DB00241 | |
| Drug | Butabarbital | 5.25e-12 | 10 | 126 | 6 | DB00237 | |
| Drug | Bromazepam | 5.25e-12 | 10 | 126 | 6 | DB01558 | |
| Drug | Barbituric acid derivative | 5.25e-12 | 10 | 126 | 6 | DB01496 | |
| Drug | Barbital | 5.25e-12 | 10 | 126 | 6 | DB01483 | |
| Drug | Hexobarbital | 5.25e-12 | 10 | 126 | 6 | DB01355 | |
| Drug | Aprobarbital | 5.25e-12 | 10 | 126 | 6 | DB01352 | |
| Drug | Amobarbital | 5.25e-12 | 10 | 126 | 6 | DB01351 | |
| Drug | Heptabarbital | 5.25e-12 | 10 | 126 | 6 | DB01354 | |
| Drug | Butethal | 5.25e-12 | 10 | 126 | 6 | DB01353 | |
| Drug | Methylphenobarbital | 5.25e-12 | 10 | 126 | 6 | DB00849 | |
| Drug | Oxazepam | 5.25e-12 | 10 | 126 | 6 | DB00842 | |
| Drug | Primidone | 5.25e-12 | 10 | 126 | 6 | DB00794 | |
| Drug | Midazolam | 5.25e-12 | 10 | 126 | 6 | DB00683 | |
| Drug | Flurazepam | 5.25e-12 | 10 | 126 | 6 | DB00690 | |
| Drug | CNQX | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 5.53e-12 | 126 | 126 | 12 | CID000002821 |
| Drug | alpha-methyl-4-carboxyphenylglycine | 6.61e-12 | 32 | 126 | 8 | CID000001222 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 8.69e-12 | 33 | 126 | 8 | CID000002071 | |
| Drug | LY354740 | 9.11e-12 | 51 | 126 | 9 | CID000114827 | |
| Drug | Thiopental | 1.15e-11 | 11 | 126 | 6 | DB00599 | |
| Drug | Alprazolam | 1.15e-11 | 11 | 126 | 6 | DB00404 | |
| Drug | Temazepam | 1.15e-11 | 11 | 126 | 6 | DB00231 | |
| Drug | Nitrazepam | 1.15e-11 | 11 | 126 | 6 | DB01595 | |
| Drug | Lorazepam | 1.15e-11 | 11 | 126 | 6 | DB00186 | |
| Drug | Phenobarbital | 1.15e-11 | 11 | 126 | 6 | DB01174 | |
| Drug | Triazolam | 1.15e-11 | 11 | 126 | 6 | DB00897 | |
| Drug | Clorazepate | 1.15e-11 | 11 | 126 | 6 | DB00628 | |
| Drug | N-Ac-D-E | 1.32e-11 | 53 | 126 | 9 | CID000005255 | |
| Drug | ketamine | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 SERPINE1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.81e-11 | 262 | 126 | 15 | CID000003821 |
| Drug | benzyloxyaspartate | 2.37e-11 | 37 | 126 | 8 | CID004133412 | |
| Drug | Flunitrazepam | 2.86e-11 | 6 | 126 | 5 | DB01544 | |
| Drug | DMCM | 2.99e-11 | 38 | 126 | 8 | CID000104999 | |
| Drug | L-BMAA | 2.99e-11 | 38 | 126 | 8 | CID000028558 | |
| Drug | 4CPG | 2.99e-11 | 38 | 126 | 8 | CID000005115 | |
| Drug | YM90K | 3.06e-11 | 23 | 126 | 7 | CID005486547 | |
| Drug | DETC-MeSO | 3.74e-11 | 39 | 126 | 8 | CID003035711 | |
| Drug | hydroxybutyrate | GRIN2A GRIN2B GRINA NRXN2 NNT GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.19e-11 | 115 | 126 | 11 | CID000010413 |
| Drug | 3,5-dihydroxyphenylglycine | 4.25e-11 | 60 | 126 | 9 | CID000108001 | |
| Drug | CGP 39653 | 4.30e-11 | 24 | 126 | 7 | CID006437837 | |
| Drug | L000369 | 5.76e-11 | 41 | 126 | 8 | CID003931705 | |
| Drug | CGP55845 | 5.76e-11 | 41 | 126 | 8 | CID000123885 | |
| Drug | CGP 35348 | 5.78e-11 | 62 | 126 | 9 | CID000107699 | |
| Drug | CCD 1042 | 5.94e-11 | 25 | 126 | 7 | CID000038022 | |
| Drug | gavestinel | 5.94e-11 | 25 | 126 | 7 | CID006450546 | |
| Drug | 2-methyl-6-styrylpyridine | 7.38e-11 | 14 | 126 | 6 | CID000235382 | |
| Drug | Joro spider toxin | 8.66e-11 | 43 | 126 | 8 | CID000119582 | |
| Drug | L-689,560 | 1.09e-10 | 27 | 126 | 7 | CID000121918 | |
| Drug | enflurane | GRIN2A GRIN2B GRINA GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.36e-10 | 68 | 126 | 9 | CID000003226 |
| Drug | DCG-IV | 1.36e-10 | 68 | 126 | 9 | CID000115114 | |
| Drug | gamma-aminobutyric acid | GRIN2A GRIN2B GRINA GRM2 PKD1L3 GRM3 GRM5 GRM6 GRM7 SLC12A2 VPS13A BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.38e-10 | 474 | 126 | 18 | CID000000119 |
| Drug | C-PP | 1.44e-10 | 28 | 126 | 7 | CID000001228 | |
| Drug | aptiganel | 1.44e-10 | 28 | 126 | 7 | CID000060839 | |
| Drug | pentylenetetrazol | GRIN2A GRIN2B GRINA GRM3 GRM5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.59e-10 | 130 | 126 | 11 | CID000005917 |
| Drug | phaclofen | 1.78e-10 | 70 | 126 | 9 | CID000001641 | |
| Drug | flurothyl | 1.84e-10 | 47 | 126 | 8 | CID000009528 | |
| Drug | AC1NUW3V | 1.89e-10 | 29 | 126 | 7 | CID005462126 | |
| Drug | ketobemidone | 1.89e-10 | 29 | 126 | 7 | CID000010101 | |
| Drug | biotinyl-L-lysine | GRIN2A GRIN2B GRINA GRM3 BSN GABRA1 GABRA2 GABRA4 GABRA5 GABRA6 | 1.93e-10 | 99 | 126 | 10 | CID000083814 |
| Drug | T2755 | 2.03e-10 | 71 | 126 | 9 | CID000005514 | |
| Drug | tetradotoxin | GRIN2A GRIN2B GRINA GRM2 GRM3 GRM5 GRM6 GRM7 CCKAR FAT1 BSN GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.36e-10 | 428 | 126 | 17 | CID000020382 |
| Drug | cis-2,3-piperidine dicarboxylic acid | 2.46e-10 | 30 | 126 | 7 | CID000001226 | |
| Drug | LY293558 | 2.46e-10 | 30 | 126 | 7 | CID000127894 | |
| Drug | GYKI 53655 | 2.46e-10 | 30 | 126 | 7 | CID000126757 | |
| Disease | Schizophrenia | CAMK2B MC5R GRIN2A GRIN2B GRM2 GRM3 GRM5 GRM7 CCKAR NRXN3 SLC12A2 NRXN1 NRXN2 SLC26A7 TMEM245 PLCL2 LRP2 GABRA1 GABRA4 GABRA5 GABRA6 | 1.74e-10 | 883 | 126 | 21 | C0036341 |
| Disease | Autistic Disorder | GPR155 GRIN2A GRIN2B NRXN3 NRXN1 NRXN2 SERPINE1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 | 1.42e-09 | 261 | 126 | 12 | C0004352 |
| Disease | Alcoholic Intoxication, Chronic | GRIN2A GRIN2B GRM2 GRM3 GRM7 CCKAR NRXN3 GABRA1 GABRA2 GABRA5 GABRA6 | 2.28e-08 | 268 | 126 | 11 | C0001973 |
| Disease | Bipolar Disorder | WFS1 GRIN2A GRIN2B GRM3 GRM5 GRM7 CCKAR TRANK1 NRXN1 GABRA1 GABRA3 GABRA5 | 1.02e-06 | 477 | 126 | 12 | C0005586 |
| Disease | Autism Spectrum Disorders | 1.78e-06 | 85 | 126 | 6 | C1510586 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 2.64e-06 | 23 | 126 | 4 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 2.64e-06 | 23 | 126 | 4 | C0393682 | |
| Disease | Uncinate Epilepsy | 2.64e-06 | 23 | 126 | 4 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 2.64e-06 | 23 | 126 | 4 | C0014556 | |
| Disease | bipolar disorder (is_implicated_in) | 6.93e-06 | 29 | 126 | 4 | DOID:3312 (is_implicated_in) | |
| Disease | Mood Disorders | 8.18e-06 | 168 | 126 | 7 | C0525045 | |
| Disease | Mental Depression | 1.41e-05 | 254 | 126 | 8 | C0011570 | |
| Disease | Niemann-Pick disease type C1 (implicated_via_orthology) | 1.81e-05 | 2 | 126 | 2 | DOID:0070113 (implicated_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | SLC22A23 GRIN2A PKD1L3 GRM3 GRM5 GRM7 ASXL3 PLCL2 NAV2 GABRA1 GABRA2 | 3.27e-05 | 566 | 126 | 11 | EFO_0007660, EFO_0008354 |
| Disease | Depressive disorder | 3.56e-05 | 289 | 126 | 8 | C0011581 | |
| Disease | Tremor, Rubral | 4.09e-05 | 16 | 126 | 3 | C0750940 | |
| Disease | Ataxia, Appendicular | 4.09e-05 | 16 | 126 | 3 | C0750937 | |
| Disease | Ataxia, Motor | 4.09e-05 | 16 | 126 | 3 | C0278161 | |
| Disease | Ataxia, Sensory | 4.09e-05 | 16 | 126 | 3 | C0240991 | |
| Disease | Abnormal coordination | 4.09e-05 | 16 | 126 | 3 | C0520966 | |
| Disease | Ataxia, Truncal | 4.09e-05 | 16 | 126 | 3 | C0427190 | |
| Disease | Addicted to cocaine | 5.41e-05 | 3 | 126 | 2 | C0858355 | |
| Disease | Niemann-Pick disease (implicated_via_orthology) | 1.08e-04 | 4 | 126 | 2 | DOID:14504 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.34e-04 | 447 | 126 | 9 | C3714756 | |
| Disease | Ataxia | 1.63e-04 | 25 | 126 | 3 | C0004134 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.84e-04 | 26 | 126 | 3 | DOID:9351 (implicated_via_orthology) | |
| Disease | childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement | 2.68e-04 | 6 | 126 | 2 | EFO_0004847, EFO_0008361, MONDO_0005405 | |
| Disease | Coxsackievirus Infections | 2.68e-04 | 6 | 126 | 2 | C0010246 | |
| Disease | Myocarditis | 2.68e-04 | 6 | 126 | 2 | C0027059 | |
| Disease | Carditis | 2.68e-04 | 6 | 126 | 2 | C0869523 | |
| Disease | Epilepsy, Cryptogenic | 4.29e-04 | 82 | 126 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 4.29e-04 | 82 | 126 | 4 | C0751111 | |
| Disease | Aura | 4.29e-04 | 82 | 126 | 4 | C0236018 | |
| Disease | breast carcinoma | USP28 GRM3 GRM7 GTF2IRD2B NRXN3 SLC12A2 ZNF37A SLC22A4 PLCL2 GTF2IRD2 GPC5 NNT KLHL18 | 4.29e-04 | 1019 | 126 | 13 | EFO_0000305 |
| Disease | smoking status measurement | LAMC3 GRIN2A GRM5 GRM7 RFX3 NRXN3 NRXN1 NRXN2 LNPEP PLCL2 SERPINE1 NAV2 CAMTA1 GABRA6 | 4.47e-04 | 1160 | 126 | 14 | EFO_0006527 |
| Disease | placental insufficiency (biomarker_via_orthology) | 4.98e-04 | 8 | 126 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.98e-04 | 8 | 126 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | acetylcarnitine measurement | 4.98e-04 | 8 | 126 | 2 | EFO_0021038 | |
| Disease | butyrylcarnitine measurement | 4.98e-04 | 8 | 126 | 2 | EFO_0020010 | |
| Disease | Developmental delay (disorder) | 5.31e-04 | 37 | 126 | 3 | C0424605 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 6.21e-04 | 39 | 126 | 3 | EFO_0008298 | |
| Disease | nervonoylcarnitine (C24:1) measurement | 6.39e-04 | 9 | 126 | 2 | EFO_0800549 | |
| Disease | epilepsy (implicated_via_orthology) | 6.90e-04 | 163 | 126 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | high density lipoprotein cholesterol measurement, multiple sclerosis | 7.96e-04 | 10 | 126 | 2 | EFO_0004612, MONDO_0005301 | |
| Disease | alcohol consumption measurement | NPC1 USP28 LAMC3 GRIN2B PKD1L3 GRM3 GRM5 FMNL2 NRXN3 NRXN1 CAMTA1 MGA GABRA2 GABRA4 | 8.70e-04 | 1242 | 126 | 14 | EFO_0007878 |
| Disease | neurotic disorder | 9.40e-04 | 101 | 126 | 4 | EFO_0004257 | |
| Disease | Semantic-Pragmatic Disorder | 9.70e-04 | 11 | 126 | 2 | C0454655 | |
| Disease | lignoceroylcarnitine (C24) measurement | 9.70e-04 | 11 | 126 | 2 | EFO_0800541 | |
| Disease | Auditory Processing Disorder, Central | 9.70e-04 | 11 | 126 | 2 | C0751257 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 9.70e-04 | 11 | 126 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | Language Delay | 9.70e-04 | 11 | 126 | 2 | C0023012 | |
| Disease | Language Development Disorders | 9.70e-04 | 11 | 126 | 2 | C0023014 | |
| Disease | vascular dementia (is_marker_for) | 9.70e-04 | 11 | 126 | 2 | DOID:8725 (is_marker_for) | |
| Disease | Speech Delay | 9.70e-04 | 11 | 126 | 2 | C0241210 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.09e-03 | 105 | 126 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | thrombin-antithrombin complex measurement | 1.16e-03 | 12 | 126 | 2 | EFO_0007775 | |
| Disease | tryptophan betaine measurement | 1.16e-03 | 12 | 126 | 2 | EFO_0021017 | |
| Disease | hexanoylcarnitine measurement | 1.16e-03 | 12 | 126 | 2 | EFO_0021040 | |
| Disease | autistic disorder (is_marker_for) | 1.16e-03 | 12 | 126 | 2 | DOID:12849 (is_marker_for) | |
| Disease | cognitive function measurement | KNTC1 SZT2 SLC22A23 ABCC5 LAMC3 GRIN2A GRIN2B ZSWIM6 PKD1L3 GRM3 GRM7 NRXN3 NRXN1 TMEM245 PLCL2 | 1.20e-03 | 1434 | 126 | 15 | EFO_0008354 |
| Disease | Epilepsy | 1.25e-03 | 109 | 126 | 4 | C0014544 | |
| Disease | Crohn Disease | 1.29e-03 | 50 | 126 | 3 | C0010346 | |
| Disease | homostachydrine measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0021164 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0800547 | |
| Disease | cerotoylcarnitine (C26) measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0800542 | |
| Disease | cleft lip | 1.42e-03 | 284 | 126 | 6 | EFO_0003959 | |
| Disease | pneumonia, COVID-19 | 1.43e-03 | 113 | 126 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | Drug habituation | 1.52e-03 | 115 | 126 | 4 | C0013170 | |
| Disease | Drug abuse | 1.52e-03 | 115 | 126 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.52e-03 | 115 | 126 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.52e-03 | 115 | 126 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.52e-03 | 115 | 126 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.52e-03 | 115 | 126 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.52e-03 | 115 | 126 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.52e-03 | 115 | 126 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.52e-03 | 115 | 126 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.57e-03 | 116 | 126 | 4 | C0740858 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 1.59e-03 | 14 | 126 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | neuropsychological test | 1.60e-03 | 197 | 126 | 5 | EFO_0003926 | |
| Disease | obsolete_red blood cell distribution width | EP400 SLC22A23 DUSP1 ABCC5 DUOX2 GTF2IRD2B MROH8 SLC12A2 MFSD14B SLC22A4 SLC22A5 PLCL2 VPS13A GTF2IRD2 | 1.87e-03 | 1347 | 126 | 14 | EFO_0005192 |
| Disease | alcohol use disorder (is_implicated_in) | 2.09e-03 | 16 | 126 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | T-Cell Lymphoma | 2.09e-03 | 16 | 126 | 2 | C0079772 | |
| Disease | reaction time measurement | 2.11e-03 | 658 | 126 | 9 | EFO_0008393 | |
| Disease | response to opioid | 2.28e-03 | 61 | 126 | 3 | EFO_0008541 | |
| Disease | mosquito bite reaction itch intensity measurement | 2.31e-03 | 129 | 126 | 4 | EFO_0008377 | |
| Disease | Cannabis Dependence | 2.36e-03 | 17 | 126 | 2 | C0006870 | |
| Disease | Psychoses, Substance-Induced | 2.36e-03 | 17 | 126 | 2 | C0033941 | |
| Disease | cup-to-disc ratio measurement | 2.54e-03 | 430 | 126 | 7 | EFO_0006939 | |
| Disease | Global developmental delay | 2.58e-03 | 133 | 126 | 4 | C0557874 | |
| Disease | smoking cessation | 2.78e-03 | 325 | 126 | 6 | EFO_0004319 | |
| Disease | Crohn's disease | 2.92e-03 | 441 | 126 | 7 | EFO_0000384 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 2.95e-03 | 19 | 126 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | oleoylcarnitine measurement | 2.95e-03 | 19 | 126 | 2 | EFO_0021043 | |
| Disease | gestational age | 2.95e-03 | 138 | 126 | 4 | EFO_0005112 | |
| Disease | Alcohol abuse | 2.98e-03 | 67 | 126 | 3 | C0085762 | |
| Disease | apolipoprotein A 1 measurement | 3.52e-03 | 848 | 126 | 10 | EFO_0004614 | |
| Disease | Psychoses, Drug | 3.60e-03 | 21 | 126 | 2 | C0033937 | |
| Disease | Attention Deficit Disorder | 3.95e-03 | 22 | 126 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 3.95e-03 | 22 | 126 | 2 | C1321905 | |
| Disease | gait measurement | 3.97e-03 | 150 | 126 | 4 | EFO_0007680 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMATTQGVRAVTSVT | 2696 | Q96L91 | |
| ITATAATITTTMVAA | 896 | Q4VCS5 | |
| VASVMGSLSQSATVF | 386 | Q9Y6Y1 | |
| IAGISTSVMTFRSLS | 411 | Q9N2K0 | |
| TTTMCVSVSLSGSVV | 791 | Q14416 | |
| TTMCISVSLSGFVVL | 801 | Q14832 | |
| MGTSVSVSTFNLVAI | 121 | P32238 | |
| EQATVSMGTTVRAAL | 1381 | Q9C0F0 | |
| SRTTIGVEFSTRTVM | 41 | P57735 | |
| SAMVRVISVSTSERT | 156 | Q6P2E9 | |
| MITLVTGLASVTSRT | 581 | Q8IWA4 | |
| TGLASVTSRTSMGII | 586 | Q8IWA4 | |
| TGAIMTTETTKTARA | 736 | Q14126 | |
| LVQGMSVSASVFTLV | 121 | Q9GZQ6 | |
| ISEDTRVVFRSTSAM | 156 | O75140 | |
| LSETVSIGSFVGMVT | 1676 | Q14517 | |
| VVGRTTQSLGVMSSA | 71 | Q8WXI7 | |
| GMVTSLVASSRAVTS | 10986 | Q8WXI7 | |
| TGSTAAVFHAVSMIA | 66 | P57723 | |
| AEVIRESSSTTGMVV | 386 | P58400 | |
| ESSSTTGMVVGIVAA | 391 | P58400 | |
| SLMEQISSVVTRFTA | 1056 | P41594 | |
| TTAVCFTVVIFSMQT | 261 | Q7Z429 | |
| TSLVVVTAAASSSMV | 1696 | Q8IWI9 | |
| AVATESMTFTLISVV | 551 | P78333 | |
| EIITSGMVISTFVSA | 341 | Q7Z3F1 | |
| TGLNRTTVTMITVSG | 306 | P40199 | |
| VAASSAVMGLIETTR | 151 | Q86YB7 | |
| ATVRAMSSVGIQTIS | 2656 | Q9UPA5 | |
| ILSRGTAASVSFMFS | 1081 | Q9NRD8 | |
| ARTVFGVTTVLTMTT | 281 | P47869 | |
| TTTMTTTVCARLAIG | 131 | Q8NH48 | |
| MTRGRITTATTGAFS | 6706 | Q7Z5P9 | |
| TVTQSRLMSIVSALF | 376 | O94915 | |
| RMAFVTSSAAASVLT | 81 | Q8TDV5 | |
| VEVIRESSSTTGMVV | 1626 | Q9P2S2 | |
| ESSSTTGMVVGIVAA | 1631 | Q9P2S2 | |
| IRESSSTTGMVVGIV | 1561 | Q9Y4C0 | |
| QTAGMITTVSFTFIE | 436 | Q8IUZ0 | |
| TVTERGFGTMLSSVA | 146 | Q6UWV2 | |
| TSMTFRGSVTISVQA | 186 | Q9UIQ6 | |
| STGHNISRVTFMSAV | 211 | Q9UIQ6 | |
| ISRVTFMSAVSSQEK | 216 | Q9UIQ6 | |
| SSRMLFVFATSTTTT | 1861 | P50748 | |
| ARTVFGVTTVLTMTT | 306 | P34903 | |
| ARTVFGVTTVLTMTT | 281 | P14867 | |
| FGITTVLTMTTLSIS | 291 | P48169 | |
| VFGVTTVLTMTTLSI | 291 | P31644 | |
| ARTVFGITTVLTMTT | 271 | Q16445 | |
| TDGTNRTVFASISMV | 1806 | P98164 | |
| TASDMVSTSRILVAV | 56 | O00232 | |
| ASTGIAVFIVMTQSV | 286 | Q86V85 | |
| AEVIRESSSTTGMVV | 1391 | Q9ULB1 | |
| ESSSTTGMVVGIVAA | 1396 | Q9ULB1 | |
| TFSGVIAMATFLTVI | 201 | Q8NH18 | |
| SLSSSMRQEVFVTIA | 146 | Q9H579 | |
| VTRFMETADSTTAAV | 4176 | Q9UPN3 | |
| GMSRVASVSQNAIVS | 311 | O75694 | |
| ITRAFTVSMKGSRVE | 1171 | O15118 | |
| EVIRESSSTTGMVVG | 581 | P58401 | |
| SSSTTGMVVGIVAAA | 586 | P58401 | |
| AVGMSVEFVSHITRS | 1201 | Q9UHC9 | |
| VIASVVTFSVHMTLG | 411 | O15440 | |
| ILVVTFSMVASSVTT | 46 | P81408 | |
| FDQRLTFTIGTSMTT | 286 | Q8N9I9 | |
| VAVVGASASSVSIMV | 146 | O15303 | |
| TVVTSMSSNRSAAGV | 411 | O94889 | |
| FSTIRREMSTFASVG | 596 | O15354 | |
| ATVFALSTMISSIQV | 161 | Q8WXF7 | |
| MAVLDRGTSTTTVFN | 326 | P28562 | |
| GEVTRFVSSSQRMLT | 241 | Q96CU9 | |
| TVTMVRVVTTSANSA | 521 | P85037 | |
| VRFLGSMAVKTDSTT | 496 | Q8NEU8 | |
| MDVGFSRTTVQTLSR | 1 | Q68D51 | |
| AMTALGVTATVARSF | 561 | Q674R7 | |
| VVASGTLSMGSEVVA | 496 | Q96PY5 | |
| SSARQRTSMQGAVTV | 226 | P33032 | |
| TVGCSAATFVFARTM | 796 | P14616 | |
| RSFKAVVTAATMSSR | 861 | Q14831 | |
| SVVMSTVAQGVSTSA | 361 | Q7Z589 | |
| SSETRMVVTFLVSAL | 16 | Q86UP8 | |
| SSETRMVVTFLVSAL | 16 | Q6EKJ0 | |
| TESRTTNGMTTVRFV | 506 | Q16348 | |
| VRNMAVGVTSTASRV | 456 | Q9H015 | |
| TVVRNMGVGVSSTAS | 456 | O76082 | |
| VNVTVVMGTRTFSNI | 91 | A0A1B0GVH4 | |
| AMISVSGVFSVTFSV | 136 | Q5SR56 | |
| STRVKVFSSSMQLVG | 291 | Q6VVB1 | |
| TVASSSTAVIVSARM | 356 | P05121 | |
| GAMETTRVTVIFAGS | 1596 | Q6ZRI0 | |
| VSALSAVMGVTLTAA | 811 | Q13423 | |
| FTALVTSMAGDTSVR | 2561 | Q5T011 | |
| TTMLATRNFSVGRQT | 306 | Q13554 | |
| VKSIATITVGMVAFS | 261 | Q5M8T2 | |
| VTGTVRTFSLKGMTT | 346 | O95219 | |
| FTATTTAVATAVGMN | 151 | Q96NB2 | |
| RLVASESQTVGSMTV | 606 | Q8N103 | |
| TTSSAMTSTIGFRVF | 281 | Q8N4C6 | |
| IVVTVSEGAMRASET | 101 | P22670 | |
| AQVTTVVSSHSMVGT | 101 | P48380 | |
| GLTVALSVNVTMFST | 271 | A1A5C7 | |
| RGFTTAAAVHVFTSM | 211 | P58743 | |
| RESSSTTGMVVGIVA | 556 | Q9HDB5 | |
| SSHIASIRMGTTVAT | 71 | O14841 | |
| TGHTMTSQIVFRSVI | 486 | Q9UPR0 | |
| TVFNSLDMSRSVSVT | 201 | O00291 | |
| AMITASGVTVTSRSA | 1156 | Q8IVL1 | |
| RTFFSSAVTVVGLLM | 1621 | Q7Z443 | |
| MVIRVYIASSSGSTA | 1 | O75368 | |
| AVTVVGFLMASISSS | 66 | Q14714 | |
| TTGVTVRTSAEFLMK | 466 | Q8NEM2 | |
| TGLASIIAATMARTV | 216 | Q9BUU2 | |
| SVIGIALVVASASMS | 231 | Q8IY50 | |
| MITSQGSVSFRDVTV | 1 | P17032 | |
| TVMASVLLVASSFSG | 331 | Q8WWU5 | |
| ARAVVSMTVSTSNAA | 96 | Q86W33 | |
| VISSAGTHSVAMVTA | 541 | P52747 | |
| MASSTFQGIKRATET | 3016 | Q96RL7 | |
| ASTSTKVRVVAVGMA | 126 | Q9NZQ8 | |
| VASGTGAVVTSLFMT | 16 | Q9BZJ4 | |
| TMSVISGISSRGSTV | 1056 | Q8N3U4 | |
| MVIRVFIASSSGFVA | 1 | Q9UJC5 | |
| VTFTATGYVVVTSSM | 421 | Q15269 | |
| TGYVVVTSSMDGTVR | 426 | Q15269 | |
| MATVVTTITGLSTSA | 326 | P55011 | |
| AAAVMSSSKVTTVLR | 236 | Q9H0E3 | |
| GRRSQTVSAIATTAM | 1696 | P24821 | |
| GDRVAVEVVTTMTSA | 541 | Q9C0C9 | |
| FAAVMESIQGVSTVT | 1061 | Q96RU2 | |
| VMSRNVSLLFTTVTT | 626 | Q9H330 | |
| SIVATTVMSNSTIVR | 951 | Q9HCJ5 | |
| VVVSRVTSSLAMLSD | 26 | Q9Y6M5 | |
| FLVGVFTTMSSDSIV | 91 | O15050 | |
| AMTTGAATHVVTSQV | 181 | Q8TE54 | |
| ISFRFTSEGMNTITV | 941 | Q8WY21 | |
| VVRSVFMSSTTSASG | 516 | O94874 | |
| ASFSVVGMVKSLTRS | 616 | O76024 | |
| TFVASMSIARSTVGV | 581 | Q9NR64 | |
| ASSSVQAATVTVMGA | 1321 | Q9Y6N6 | |
| TGISVMVSRSNGTVS | 531 | Q12879 | |
| ETGISVMVSRSNGTV | 531 | Q13224 |